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Abstract 
 
Canada and the United States (US) are both high income, low tuberculosis (TB) incidence 
countries with similar TB control programs, yet an explicit comparison of TB incidence over time 
is lacking. 
Objective one explored the impact of TB and other disease case definition change, and 
methods to control for the change via a general literature search. Underreporting/increases in 
reported cases and differences in sensitivity and specificity measures were among others noted 
to arise from changes in case definition. For appropriate comparisons within and between 
populations, consistent ascertainment criteria of cases should be adopted. 
Objective 2 explored and compared TB incidence rates in Canada and the US from 1953-
2015. TB rate from 1953-2015 was retrieved for both countries. Joinpoint and direct 
standardization were performed. Canada’s TB rates/100,000 were higher from 1953-1974. 
Canada’s average annual percent change in rate from 1975-2015 was -2.9% compared to the US 
-4.1%. Case definition change, HIV+/TB co-infection, and Foreign-born (FB) TB were the main 
contributors to the differences. 
Objective three compared the rate of TB decline in subpopulations. TB cases and 
population by ethnicity from 2001-2011, and the percent of HIV+/TB co-infection cases from 
1997-2012 were retrieved for Canada and the US. Segmented and decomposition analysis was 
performed. FB and Indigenous TB rate declined by -3.7% and -6.3% in the US and by -1.7% and -
4.5% in Canada. Changes in age-specific rates declined overall rates in Canada by 80.1% and the 
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US at 66.7%. Overall, the percentage of HIV+/TB cases declined more rapidly in the US than in 
Canada. After adjusting for age, FB and Indigenous populations, rates decline more in the US 
than in Canada. 
Objective four forecasted and then compared year-over-year TB rates between Canada 
and US from 2017-2035. TB rate from 1975-2016 and rates by ethnicity from 1993-2016 were 
retrieved for both countries. Autoregressive integrated moving average and multivariate vector 
autoregression models were performed. The forecasted models showed a gradually decreasing 
trend from 2017-2035, reaching a rate of 2.2 for Canada and 1.3 for the US by 2035. The 
prediction suggests that achieving 2035 WHO set target could be a challenge for both countries. 
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Chapter 1. Introduction/Literature review 
 
Tuberculosis (TB) is an ancient infection (Dutt, 2011) that affects quality of life (Hansel et al., 
2004), and has a high mortality rate (Dye, 2006). Measured in disability-adjusted years of life 
lost, over 80% of the burden of TB is attributed to premature death rather than illness (Dye, 
2006). In 2014, an estimated 1.5 million deaths due to tuberculosis were recorded in the global 
population (WHO, 2015), and in 2016, that increased to 1.7 million worldwide (CDC, 2018). 
Although both developed and resource-limited countries are faced with TB-related deaths, 
most occur in resource-limited countries (Mohajan, 2015). Factors that may potentially 
contribute to increasing the rate of tuberculosis among individuals living in resource-limited 
countries include poor management (Gondil et al., 2018), while others, such as overcrowding 
(Kompala et al., 2013) and HIV infections (Dye et al., 1999), are considered potential risk factors 
for the onset of TB.  
Despite control measures in developed countries designed to eliminate TB, factors continue to 
hinder TB elimination. For instance, Clark et al. found that overcrowded housing in First Nations 
communities increased an individual’s risks of TB infection (Clark et al., 2002). Wolleswinkel-van 
den Bosch et al. reported that a high proportion of new tuberculosis cases observed in the 
Dutch population might be attributed in part to infections from migrant populations 
(Wolleswinkel-Van den Bosch et al., 2002). Also, McBryde and Denholm found an elevated 
incidence of TB among immigrants in Australia especially individuals emigrated from South Asia 
and sub-Saharan Africa (McBryde & Denholm, 2012). 
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Over the years, the United States and Canada have implemented prevention and intervention 
based programs to reduce the incidence of TB. Examples of existing TB programs include: the 
national TB program (CDC, 2015) and Minnesota Department of Health TB prevention and 
control program (Minnesota Department of Health, 2018) in the United States; and TB Service 
for First Nations communities in BC (First Nations Authority, 2018) and TB Prevention and 
Control Saskatchewan (Saskatchewan Health Authority, 2017) in Canada. 
Although both Canada and the United States have had some success in TB control, the rate of 
TB decline began to differ between the countries after experiencing the same incidence rate in 
2004 (Gallant et al., 2012; CDC, 2017).  
This chapter will focus on a brief description of TB risks worldwide, including specific details on 
the United States and Canada, the global, local and country-specific economic burden of TB, 
clinical/laboratory diagnostics, transmission and pathogenesis of TB, as well as highlight risk 
factors for TB. 
1.1  Epidemiology of Tuberculosis 
 
1.1.1 Tuberculosis Pathogenesis and Transmission 
Human TB is known to be caused by Mycobacterium tuberculosis (Glickman et al., 2001). 
Virtually any human body organ can be infected by the bacteria (Dutt, 2011); however, the 
most frequently used portal of infection is the lungs (Dutt, 2011). Although other modes of 
transmission are rare (Glazious et al., 2014), the most common route is between an infectious 
pulmonary TB patient and a susceptible individual by droplet nuclei (Dutt, 2011; Glazious et al., 
2014), aerosolized by means such as talking, sneezing, coughing and singing (Dutt, 2011). Other 
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identified factors that may facilitate the transmission of tuberculosis especially in a resource-
limited environment include overcrowding and poor ventilation (Kompala et al., 2013); both are 
mechanisms that increase transmission of an aerosolized pathogen.  
TB pathogenesis encompasses many phases or stages which include: exposure, primary 
infection and clinical disease (Long et al., 2014). Previously naive individuals infected with 
Mycobacterium TB will develop primary infection about 5% of the time (Long et al., 2014). 
Without prophylaxis, of the 95% that do not develop active disease (or primary TB) within two 
years of infection, about 5% will develop reactivation TB later in life if they are otherwise 
healthy (Long et al., 2014). However, the remaining 90% with LTBI never progresses to develop 
TB disease (Long et al., 2014). Among individuals with latent TB infection, the development of 
active TB can be made possible by factors classed as bacterial, host and/or environmental 
conditions (Getahun et al., 2015). Additionally, other immune suppressors such as Human 
Immunodeficiency Virus (HIV) infection (Selweyn et al., 1989), and end-stage renal disease 
(Yousef et al., 2014) among others, have been identified as important factors for the 
development of active TB.  
The pathogenesis of post-primary TB or reinfection continues to be a controversial issue. While 
some studies support the argument of exogenous reinfection (Van Rie et al., 1999; Shen et al., 
2006), others do not (Stead, 1967; Arend & Van Dissel, 2002). For example, William Stead noted 
that exogenous reinfection should not be considered as an important factor but rather use 
observed evidence showing that “chronic pulmonary tuberculosis develops from reactivation of 
dormant foci implanted during primary infection” (Stead, 1967). 
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Figure 1-1 describes the various
 
stages in the pathogenesis of tuberculosis.   
 
Figure 1-1: Phases of Tuberculosis Pathogenesis. Source: Canadian TB Standards Edition 7 with 
permission from Public Health Agency of Canada 
 
1.1.2. Clinical/Laboratory Diagnostics 
 
Diagnosis of TB is usually performed using standard algorithms or procedures which in most 
cases start with the ascertainment of medical history (e.g., HIV status, TB exposure, and other 
health conditions) and physical examination including pulmonary examination and lymph node 
examination for TB suspects (Jacobson, 2017; CDC, 2013).  A test for Mycobacterium 
tuberculosis infection detection may be followed using either Mantoux tuberculin skin test 
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(TST) or Interferon-gamma release assays (IGRAs) (CDC, 2013). Despite its wide usage and 
soaring popularity, the TST requires highly skilled persons to administer and read test results to 
avoid false readings (Nayak & Acharjya, 2012). The IGRAs besides being more specific than the 
TST (Pai & Menzies, 2007), they are preferred choice for testing TB infection in individuals 
previously exposed to Bacillus Calmette-Guérin vaccination (Jacobson, 2017; Pai & Menzies, 
2007). However, when it comes to the cost and simplicity of test procedure, the TST is 
preferable (WHO, 2011). Although the three components earlier highlighted cannot be 
underestimated in TB diagnostics, more rigorous testing algorithms are subsequently applied to 
test for active TB (Pai et al., 2014). These include chest radiography, smear microscopy, 
Mycobacterial culture and drug-susceptibility testing, and nucleic acid amplification test 
(NAATs) (CDC, 2013; Pai et al., 2014). Chest radiography is one algorithm widely recognized as a 
useful test for TB screening (Melendez et al., 2016) coupled with its highly appreciable 
sensitivity seen as a major advantage to its use, chest radiography specificity has been found to 
be poor (WHO, 2016). The smear microscopy and Mycobacterial culture are both prominent 
microbiological methods of diagnosis of TB, however, Mycobacterial culture is regarded as the 
gold standard for active TB disease detection (Pai et al., 2014). On the other hand, although, 
diagnosis and detection of TB and drug resistance may be carried out using the molecular 
method of NAATs, for definitive diagnosis Mycobacterial culture is still required (Pai et al., 
2014). 
1.1.3. Economic Burden 
 
Besides high mortality and incidence rates (WHO, 2018), exposure to TB poses a high economic 
burden on countries around the world. Annually, about 12 billion dollars (US) is spent on TB 
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worldwide (WHO, 2017); specifically, an estimated $3 billion yearly in India (John et al. 2009), 
$8-29 million yearly in Philippines (Peabody et al., 2005) and approximately 2 billion dollars 
from 2011 and beyond in Indonesia (Collins et al., 2017).  Across the European Union, a cost 
totaling nearly 6 billion euros was spent on TB in 2012 (Diel et al., 2014). Diel et al. reported 
that in Germany, on average, the costs of TB treatment for both inpatients and outpatients in 
2009 was about 7,368 euros per adult case and 7,300 euros per child case (Diel et al., 2012). 
Similar to the south and east Asian countries, a high economic burden has been observed in 
South, Central and North America. In 2013, an estimated 246 million dollars spent on 
tuberculosis control among 15 selected countries in South, Central and North America (Pan 
American Health Organization, 2013).  
The United States and Canada are not exceptions in terms of the economic burden of 
tuberculosis experienced by other countries in the world. Within the time interval 2010 to 
2014, the government of the United States contributed over $2.8 billion dollars towards the 
eradication of global TB (U.S. Government, 2014). In 2006, the direct cost of TB amounted to 
$752 million dollars in the United States (Holmquist, 2008). In Canada, overall TB-related direct 
and indirect costs amounted to $74 million Canadian dollars in 2004 (Menzies, 2008) with 
about $47,000 Canadian dollars spent to treat a single case of active TB (Menzies, 2008). The 
2004 cost per case of active TB in Canada included research, hospitalization for active TB, 
screening of health care workers, clinical care, TB drugs and laboratory test (Menzies, 2008). 
Evidence provided suggests that achieving a reduction or total elimination of TB is a crucial 
means of saving lives and reducing TB-related spending. 
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1.1.4. Incidence of Tuberculosis 
 
According to the World Health Organization, globally, about 10 million new active TB cases 
were recorded in 2017 (WHO, 2018). Among all the WHO regions most new cases of TB were 
reported in South-East Asia (44.9%), with Africa ranking second (24.9%) (Table 1-1) (WHO TB 
Control, 2018). 
In the Americas, of the 268,400 TB incident cases that were found in 2011, 67% originated from 
South America (Pan American Health Organization, 2013). Although an elevated incidence of TB 
has been observed in impoverished countries (Castañeda-Hernández et al., 2013), TB cases in 
developed countries cannot be overlooked.  
TB continues to be reported in the United States (2.9 cases per 100,000 persons in 2016) CDC, 
2017), Canada (5 cases per 100,000 in 2016), Australia (6 cases per 100,000 in 2016) and the 
United Kingdom (10 cases per 100,000 in 2016) (Public Health England, 2018). 
Table 1-1: Estimated TB Incidence, 2016 
 Incidence 
WHO Region/Some large countries 
within each region  
No. in 
thousands 
% of global total Rate/100,000 
population 
Africa 
• Nigeria, Ethiopia, DR Congo 
2590 24.9 253.9 
The Americas 
• US, Canada, Mexico 
274 2.6 27.5 
East Mediterranean  
• Afghanistan, Bahrain, Djibouti 
766 7.4 114.5 
Europe 
• Germany, France, UK 
290 2.9 31.7 
South-East Asia 
• India, DPR Korea, Indonesia 
4670 44.9 239.5 
Western Pacific 
• China, Philippines, Viet Nam 
1800 17.3 95.2 
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Global Total 10400 100 139.8 
 
Source: Global Tuberculosis Report, 2017 (Table 3.2, page 29) (WHO, 2017) with permission 
from WHO.  
2.1. Tuberculosis in Canada and the United States 
 
The TB epidemic in Canada dates back several centuries with its root traced back to the earlier 
European settlers (Grzybowski & Allen, 1999). TB was reported to be the biggest single cause of 
death in Canada in 1867 (Canadian Public Health Association, 2018), with TB-associated 
mortality reported in 1880 (nearly 200 per 100,000), 1901 (180 per 100,000), and 1908 (165 per 
100,000) (Saskatchewan Lung Association, 2018). The rate decreased to 84 per 100,000 prior to 
the emergence of the “first reliable national statistics for Canada” in 1926 (Saskatchewan Lung 
Association, 2018). The mortality rate of TB is an important epidemiologic measure imperative 
to public health practitioners as it can “give an indication of the extent of TB in a population, 
and of the size of the task faced by a national TB control programme” (United Nations, 2008). 
The TB incidence rate in Canada has also been documented annually since 1924 (Gallant et al., 
2012), ranging from 43.6 per 100, 000 in 1924 (Gallant et al., 2012) to 4.8 per 100, 000 in 2016 
(Vachon et al., 2018). Despite a dramatic improvement achieved in TB incidence rates in Canada 
after the 1980s (Gallant et al., 2012), the three decades since then have seen only moderate 
declines (Gallant et al., 2012). 
The United States, like Canada, has a long history of TB. In the nineteenth and the onset of the 
twentieth centuries, TB was the single greatest cause of death in the United States (American 
Lung Association, 2007). The available annual incidence rate of TB in the United States ranged 
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from 52.5 per 100,000 in 1953 to 2.9 per 100,000 in 2016 (CDC, 2017). However, with changes 
in the surveillance case definition, incidence rate prior to 1975 are not comparable to those in 
1975 or later (Armstrong & Miramontes, 2014). In the decade 1993 to 2003, a decrease of 44% 
was observed in the United States TB incidence (American Thoracic Society, 2005). This decline 
was attributed to a well-planned national strategy and infusion of sufficient resources after the 
first TB re-emergence in the United States (American Thoracic Society, 2005). Additionally, in 
the last two decades, that rate has continued to decline to its lowest rate of 2.9 per 100,000 in 
2014 and 2016 (CDC, 2017).  
1.2.1. Risk Factors of Tuberculosis 
 
Although active TB begins with exposure to the MTB bacillus (Chisholm et al., 2016), other 
identified potential triggers or risk factors may facilitate the progression of disease (Narasimhan 
et al., 2013). Human immunodeficiency virus (HIV) has been found to be a strong driver of both 
initial infection and progression of TB disease (Corbett et al., 2003). In addition, higher rates of 
tuberculosis have been found in individuals with chronic kidney disease (Shen et al., 2015). 
Organ transplantation has been reported as a potential factor as evidenced by an increased 
tuberculosis incidence among organ recipients (Torre-Cisneros et al., 2009). Other previous 
studies have also identified silicosis/silica exposure as a potential risk factor for tuberculosis 
(Yarahmadi et al., 2013; Farazi et al., 2015).  
Other factors such as socio-economic status (e.g. unemployment) (Sarvi et al., 2014), age, sex 
(Zhang et al., 2011), smoking (Den Boom et al., 2005), alcohol consumption (Kuznetsov et al., 
2013) and overcrowding (Kompala et al., 2013) have been found to contribute to increases in 
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TB incidence. The importance of adjusting for all these factors in TB-related research cannot be 
underestimated. Zhang et al. noted that “the occurrence of specific types of extrapulmonary TB 
significantly varied among different age groups or origins” (Zhang et al., 2011). Controlling for 
factors such as age which is known to frequently experience a shift in 
distribution/compositional difference within populations over time, through standardization 
can provide a way to ‘remove’ the effect of differences in age distribution (Ong et al., 2006).  
1.3. Tuberculosis: Foreign-born and Indigenous Population 
 
Ethnic differences continue to impede the decline of TB incidence (Noppert et al., 2017; Bakhshi 
et al., 1997). For instance, Bakhshi et al. found higher rates of tuberculosis in African Caribbean 
individuals as compared to Caucasians (Bakhshi et al., 1997). Among TB-related ethnic groups, 
Indigenous and Foreign-born populations continue to disproportionately experience an 
elevated risk of TB (Halverson et al., 2014). For instance, in 2016, Foreign-born individuals 
accounted for 70% of the reported TB cases in Canada, and Canadian born Indigenous people 
had the highest rate of 23.5 per 100, 000 population (Vachon et al., 2018). Among Indigenous 
people in Canada, First Nations individuals accounted for 63% of TB cases, followed by the Inuit 
at 34% and Métis at 3% (Vachon et al., 2018). Similarly, 68% of cases reported in the US in 2016 
were among Foreign- born and the highest rates occurred in US-born Native Hawaiian/Pacific 
Islanders (9.2 per 100, 000 population) and American Indian/Alaska Natives (5.0 per 100,000 
population) (Schmit et al., 2017). These trends are not only limited to Canada and the US but 
have also been observed in other countries (Public Health England, 2017; Chang et al., 2011) 
with 74% of TB cases in the United Kingdom reported among Foreign-born individuals (Public 
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Health England, 2017). Also, Taiwanese Aboriginals reported a rate of 176 per 100,000 
compared to 65 per 100,000 in Taiwanese Non-Aboriginals (Chang et al., 2011). Due to the 
differences observed in the different ethnic groups, controlling for these differences in TB-
related research is imperative (Ong et al., 2006). For instance, in a comparative study of TB-
related risk factors including ethnicity among 13 Malaysian states and territories, Ong et al. 
applied direct standardization to control for the effect of ethnic differences (Ong et al., 2006). 
1.4. Examples of Tuberculosis Elimination Programs in Canada and the United States  
 
There are several tuberculosis elimination programs that have been initiated in Canada and the 
United States. Some TB elimination programs available in Canada include: STOP TB Canada 
(STOP TB Canada, 2017); the Northern-Inter Tribal Health Authority TB program (NITHA) 
(NITHA, 2011); and First Nations Health Authority Tuberculosis Program in BC (FNHA, 2018). 
The STOP TB Canada program is a partner of the global STOP TB program which collaborates 
with other governmental and non-governmental organizations including “provincial and 
territorial TB programs and the International Union against TB and Lung Disease” (STOP TB 
Canada, 2017). The STOP TB Canada program’s main focus is geared towards eliminating TB in 
Canada by communicating TB-related control issues to the international, national and local 
communities and as well providing easy access to educational materials and other resources to 
enhance the fight against TB (STOP TB Canada, 2017). The NITHA TB program is another TB 
program implemented in Saskatchewan that aims to provide TB-related services including 
“orientating nurses and training community workers to administer Directly Observed Therapy 
(DOT) to clients, performing contact tracing and managing TB outbreaks” in First Nation 
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communities (NITHA, 2011). The FNHA TB service also provides TB control interventional 
programs/services for Canadian First Nation communities to “close the gap disparities of TB 
incidence in First Nations people” (FNHA, 2018). Activities carried out by the FNHA program 
include but not limited to “assurance to timely and culturally safe diagnosis, treatment and 
follow-up care for those exposed to and diagnosed with TB” (FNHA, 2018). The services are run 
on a collaborative basis among First Nations communities, provincial governments, federal 
public health agencies and other health professionals (FNHA, 2018). 
In the United States some examples of tuberculosis elimination programs include: the US 
national TB program primarily aims to “promote health and quality of life by preventing, 
controlling and eventually eliminating TB from the United States” (CDC, 2015) by conducting 
routine surveillance, resourcing laboratories and provide logistics, funding and other TB-related 
program support (CDC, 2015). The STOP TB USA, a joint effort TB program in the United States 
focused on “eliminate TB as a public health threat in the United States” by embarking on 
scientific and educational activities as well collaborate with communities to enhance TB 
prevention, care and control (STOP TB US, 2017). The Harris County Public Health (HCPH) TB 
Elimination Program focused on “TB prevention and control” (Harries County Public Health, 
2017) is another TB prevention and control program in the United States. This program 
provides a special interventional method through the “use of video Directly Observed Therapy 
(VDOT) in which health care workers observed patients taking their TB medications remotely via 
a mobile device” (Harries County Public Health, 2017).  
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1.5. Purpose of the Thesis Work 
 
No single country in the world has achieved 100% elimination of TB. Despite efforts made by 
most countries, some of whom have declining trends like Canada and the United States, TB 
remains a global health problem (Zaman, 2010). 
Although both Canada and the United States have not relented in their efforts towards the total 
elimination of tuberculosis, the differing rise and fall of tuberculosis rates (Gallant et al., 2012; 
CDC, 2017) warrant further investigation into contributing factors and country-specific 
approaches in handling the disease. For instance, since 1980 the rate of decline in annual TB 
rate slowed in Canada and for two decades within this period annual TB rates in Canada 
plateaued (Gallant et al., 2012). Although the annual decline in TB rate did not stall in the 
United States (CDC, 2017) as it did in Canada during the same time interval, the United States 
did experience a decade of a plateau (CDC, 2017). 
In spite of the same annual rate of tuberculosis observed in Canada (5.0 per 100,000) (Gallant 
et al., 2012) and the United States (5.0 per 100,000) in 2004 (CDC, 2017), over the decade 
between 2004 and 2014, the annual rate decreased in the United States (2.9 per 100,000) (CDC, 
2017) whereas Canada did not experience much of a decrease at all (4.5 per 100,000) (Gallant 
et al., 2012). Investigating factors at an ecological level that contribute to the difference in 
annual tuberculosis rate between Canada and the United States will: (1) broadly deepen our 
understanding of the tuberculosis epidemic in both countries and (2) help inform appropriate 
prevention and interventional strategies which will further reduce the disease in both 
countries. 
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 Therefore, this dissertation will explore what led to the slowed decrease of TB in Canada and 
provide some probable projections of TB pre-elimination rates for both Canada and the US. 
The chapters of the thesis will take the form of four manuscript-style chapters. Chapter 2 will 
focus on an overview of the importance of assessing surveillance case definition, identifying 
differences in TB and other disease case definition, as well uncover potential methodologies 
available to control differences in case definition. Chapter 3 will explore TB incidence rates in 
Canada and the United States over time and compare the national trends. Chapter 4 will 
compare the rates of TB decline in FB and IND TB cases, and examine the impact of shifts in FB 
and IND population by age and age-specific rates, as well the influence of HIV/TB co-infections 
over time between Canada and the United States. Finally, Chapter 5 will forecast and then 
compare year-over-year TB rates between Canada and the United States from 2017-2035. 
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Chapter 2. Surveillance Case Definition: An overview 
 
2.1. INTRODUCTION 
 
Epidemiologically, defining what is a ‘case’ is a crucial means to classify individuals as having a 
particular disease status, syndrome or other health condition (Gregg, 2008). Standardized 
classification criteria tend to enhance the specificity of disease reporting (CDC, 1997), assist in 
accurate monitoring of disease burden over time or location (WHO, 2010) and enable 
consistent reporting of diseases or notifiable conditions among geographical regions 
(Washington State Department of Health, 2015). There are different purposes in which a case 
definition may be used (Chan&Donovan, 2005). These include outbreak detection (Gregg, 
2008), service provision and improvement, surveillance, research and clinical care/diagnosis 
(Chan&Donovan, 2005). 
 However, different purposes may require different elements to be included in a case definition. 
For instance, while clinical and/or laboratory features characterize surveillance case definitions, 
restrictions on time, place and person are added to an outbreak case definition to better 
characterize the circumstances within an outbreak (Gregg, 2008; Stein et al. 2011). Notably, to 
determine the standard of clinical care or confirm clinical diagnoses, the use of a standardized 
case definition as a sole criterion is usually inadequate and often inappropriate (CDC, 1997). 
Thus, case ascertainment based on a single case definition especially in situations where 
multiple categories of the disease exist may not be adequate to capture all the relevant cases 
(National Institutes of Health, 1994). For example, a multi-faceted case definition is required to 
capture all “three dimensions of chronic fatigue syndrome (CFS): fatigue, functional impairment, 
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and eight accompanying symptoms (post-exertional malaise, impaired memory or 
concentration, sore throat, tender cervical or axillary lymph nodes, muscle pain, multi-joint pain, 
new headaches, unrefreshing sleep)” (Unger et al., 2016; Fukuda et al., 1994). 
Irrespective of the possibility of ongoing use of a surveillance case definition for a particular 
disease, in some instances, definitions are either revised, modified or changed (Selik et al. 1990; 
State of Alaska Epidemiology Bulletin, 1993; WHO, 2014) as new scientific 
information/evidence emerges (Nelson and Sifakis, 2007). Changing a case definition may not 
only result in reporting delays (Tabnak et al., 2000), over/under-estimation of disease 
prevalence (Mckeown et al., 2015) but it also inhibits the comparison of disease reporting 
between regions or between time periods (CDC, 1997). For instance, a 1993 case definition 
change in acquired immune deficiency syndrome (AIDs) in the United States (Selik et al., 1990; 
State of Alaska Epidemiology Bulletin, 1993) paved the way for all HIV-infected individuals who 
had CD4+ < 200/µL or a CD4+ percentage < 14 and individuals with invasive cervical cancer, 
pulmonary TB or recurrent pneumonia to be included (CDC, 1992). However, the change 
increased the number of cases in 1993 by 111% over the reported cases in 1992 (CDC, 1994).  
Arguably, when comparing particular disease occurrence either within or between countries, a 
consistent case definition is imperative (CDC, 1990) to avoid any bias that might arise simply 
from differences, changes, or modifications in the definition (Selik et al., 1990; State of Alaska 
Epidemiology Bulletin, 1993; CDC, 1994). 
Biases may be inevitable in every standard case definitions (Sergeant and Perkins, 2015). 
Hence, this paper seeks to epidemiologically explore how a change in case definition can impact 
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our understanding of disease by taking into account specific real-world examples, primarily 
focusing on Tuberculosis, but using examples from other diseases as required. In addition, it will 
address potential methodologies available to control for such case definition derived changes in 
the analysis of disease trend. 
2.2. METHODS 
 
The search for published studies for this paper encompasses both general literature search for 
non-specific disease case definition and TB specific case definition. Databases in which the 
search was conducted includes MEDLINE, PubMed and PMC. Besides these sources, other 
authoritative books addressing disease case definition and published national disease reports 
were also searched. The search primarily focused on the following terms: case definition (for TB 
and other diseases) with both clinical and/or laboratory features, impact of case definition 
change and case definition change adjustment methods. 
Based on the information retrieved from the search, a random selection of other disease and 
TB specific examples were chosen and compared based on similarities within or between their 
geographical regions (e.g., national versus local or two different countries within the same 
WHO regions). Similarities considered for selection and comparison of the retrieved 
information include belonging to the same WHO region (WHO, 2018), same income-level 
classification (e.g., high, low, lower middle and upper middle) (World Bank 2016), having similar 
WHO TB surveillance program (Mor et al., 2008) and low TB incidence countries (Lönnroth et al. 
2015). The comparison aimed at ascertaining any differences in case definition that might have 
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contributed to difference in disease incidence or rate especially as it relates to TB either within 
or between geographical regions. 
2.3. The case definition: why is it important to define? 
 
The impact of the changes or differences in disease case definitions has been documented in 
the published literature. For example, these impacts may manifest as differences in disease 
counts reported within or between different geographical regions (e.g., country). A local 
example of this is what counts as a case of West Nile Virus (WNV) in Saskatchewan 
(Saskatchewan Ministry of Health, 2014) versus the rest of Canada (Public Health Agency of 
Canada, 2009). Since 2009, Saskatchewan has only reported cases of West Nile Virus 
Neurological Syndrome (WNNS) while the rest of Canada includes both WNNS and West Nile 
fever (febrile cases) in their surveillance numbers (Saskatchewan Ministry of Health, 2014; 
Public Health Agency of Canada, 2009). This is in the face of substantial differences in the rate 
of reporting and diagnosis of West Nile fever as compared to WNNS diagnosis and reporting.  
Differences in the WNNS case definitions from Saskatchewan and the rest of Canada are 
outlined in Table 2-1. 
Table 2-1: Saskatchewan and Public Health Agency of Canada Case Definitions 
 
Saskatchewan Case Definition Public Health Agency of Canada Case 
Definition 
Clinical Criteria 
• History of exposure in an area where 
West Nile Virus (WNV) activity is 
occurring OR 
• History of exposure to an alternative 
mode of transmission AND 
Clinical Criteria 
• History of exposure in an area where 
West Nile Virus (WNV) activity is 
occurring OR 
• History of exposure to an alternative 
mode of transmission AND 
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• Meningitis, encephalitis, acute 
flaccid paralysis, or other acute signs 
of central or peripheral neurologic 
dysfunction, as documented by a 
physician AND 
• Absence of a more likely clinical 
explanation 
• Onset of fever AND 
Recent onset of at least one of the following: 
• Encephalitis (acute signs of central or 
peripheral neurologic dysfunction) OR 
• Viral meningitis (pleocytosis and signs 
of infection, e.g. headache, nuchal 
rigidity) OR 
• Acute flaccid paralysis (e.g. 
poliomyelitislike syndrome or 
Guillain-Barré-like syndrome) OR 
• Movement disorders (e.g. tremor, 
myoclonus) OR 
• Parkinsonism or Parkinsonian-like 
conditions (e.g. cogwheel rigidity, 
bradoykinesia, postural instability) OR 
• Other neurological syndromes 
Confirmed Case 
Clinical criteria AND at least one of the 
following laboratory criteria: 
• Four-fold or greater change in virus-
specific quantitative antibody titers 
in paired sera OR 
• Isolation of virus from, or 
demonstration of specific viral 
antigen or nucleic acid in, tissue, 
blood, CSF, or other body fluid, OR 
• Virus-specific IgM antibodies in 
serum with confirmatory virus-
specific neutralizing antibodies in the 
same or a later specimen OR 
• Virus specific IgM antibodies in 
serum with confirmatory avidity test 
in the same or later specimen OR 
• Virus-specific IgM antibodies in CSF 
and a negative result for other IgM 
antibodies in CSF for arboviruses 
endemic to the region where 
exposure occurred 
 
Confirmed Case 
Clinical criteria AND at least one of the 
confirmed case diagnostic test criteria: 
• A significant (e.g. fourfold or greater) 
change in WN virus neutralizing 
antibody titres (using a PRN or other 
kind of neutralization assay) in paired 
acute and convalescent sera, or CSF 
OR 
• Isolation of WN virus form, or 
demonstration of WN virus-specific 
genomic sequences in, tissue, blood, 
CSF or other body fluids OR 
• Demonstration of WN virus antigen in 
tissue OR 
• Demonstration of flavivirus antibodies 
in a single serum or CFS sample using 
a WN virus IgM EIA, confirmed by the 
detection of WN virus specific 
antibodies using a PRN (acute or 
convalescent specimen) OR 
• A significant (e.g. fourfold or greater) 
change in flavivirus 
haemagglutination inhibition (HI) 
titres in paired acute and 
convalescent sera or demonstration 
of a seroconversion using a WN virus 
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IGM EIA AND the detection of WN 
specific antibodies using a PRN (acute 
or convalescent serum sample)  
Sources: Saskatchewan Ministry of Health, 2014 and Public Health Agency of Canada, 2009 
 
2.4. Case definition: a special case of tuberculosis 
 
Tuberculosis like other disease research may be affected by the way the ‘cases’ are defined. As 
a result, the adaption of a standard case definition in TB research enhances the identification of 
TB case and assists in the selection of suitable standard treatment regimens (WHO, 2010). The 
following details the case definitions for tuberculosis by the WHO (WHO, 2013), USA (CDC, 
2009) and Canada (Menzies, 2014) (Table 2-2).  
Table 2-2: Comparison of Tuberculosis Surveillance Case Definition 
WHO United States Canada 
1. Bacteriologically confirmed case: 
• Someone for which a 
biological specimen is 
positive by smear 
microscopy, culture or WRD 
(such as Xpert MTB/RIF). 
 
• All such cases should be 
notified, regardless of 
whether TB treatment has 
started. 
 
 
 
 
 
 
 
 
 
1.Laboratory criteria: 
• Isolation of M. 
tuberculosis from a 
clinical specimen, OR 
 
• Demonstration of M. 
tuberculosis complex 
from a clinical 
specimen by nucleic 
acid amplification 
test, OR 
 
• Demonstration of 
acid-fast bacilli in a 
clinical specimen 
when a culture has 
not been or cannot 
be obtained or is 
falsely negative or 
contaminated. 
1.Laboratory 
confirmed case: 
• Cases with 
Mycobacterium 
tuberculosis 
complex 
demonstrated 
on culture, 
specifically M. 
tuberculosis, 
M. africanum, 
M. canetti, M. 
microti, M. 
pinniprdii or M. 
bovis 
(excluding M. 
bovis Bacillus 
Calmette 
Guérin (BCG) 
strain). 
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Sources: WHO, 2013; CDC, 2009; and Menzies, 2014. 
 
 
2. Clinical confirmed case:  
• Not bacteriologically 
confirmed but diagnosed 
with active TB by a clinician 
or other medical 
practitioner who has 
decided to give the patient 
a full course of TB 
treatment. 
 
• This definition includes 
cases diagnosed on the 
basis of X-ray abnormalities 
or suggestive histology and 
extrapulmonary case 
without laboratory 
confirmation. 
 
• Clinically diagnosed case 
subsequently found to be 
bacteriologically positive 
(before, or after starting 
treatment) should be 
reclassified as 
bacteriologically confirmed. 
 
 
2. Clinical criteria: 
Must meet all the following 
criteria 
• Positive TB skin test 
result or positive 
interferon gamma 
release assay for M. 
tuberculosis 
 
• Other signs and 
symptoms 
compatible with TB 
(e.g., abnormal chest 
radiography, 
abnormal chest 
computerized 
topography scan, or 
other chest imaging 
study, or clinical 
evidence of current 
disease) 
 
• Treatment with two 
or more anti-TB 
medications 
 
• A completed 
diagnostic evaluation 
 
 
 
 
 
 
 
2.Clinically confirmed 
case: 
Cases ascertained in 
the absence of culture 
proof, cases clinically 
compatible with active 
tuberculosis that have, 
for example: 
• chest x-ray 
changes 
compatible 
with active 
tuberculosis 
  
• active non-
respiratory 
tuberculosis 
(meningeal, 
bone, kidney, 
peripheral 
lymph nodes, 
etc) 
 
 
• pathologic or 
post-mortem 
evidence of 
active 
tuberculosis  
 
• favourable 
response to 
therapeutic 
trial of anti-
tuberculosis 
drugs 
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2.4.1. TB case definition (s) in Canada 
 
The confirmation of tuberculosis cases in Canada may be carried out through laboratory 
approaches and/or clinical examination (Pai, 2014). In Canada, the laboratory-confirmed cases 
are “cases with Mycobacterium tuberculosis complex demonstrated on culture, specifically M. 
tuberculosis, M. africanum, M. canetti, M. caprae, M. microti, M. pinnipedii or M. bovis 
(excluding M. bovis (BCG) strain)” whereas clinically confirmed cases are cases ascertained “in 
the absence of culture proof, cases clinically compatible with active tuberculosis that have, for 
example: (1) chest x-ray changes compatible with active tuberculosis; (2) active non-respiratory 
tuberculosis(meningeal, bone, kidney, peripheral lymph nodes, etc); (3) pathologic or post-
mortem evidence of active tuberculosis; (4) favourable response to therapeutic trial of 
antituberculosis drugs” (Menzies, 2014). Although from 1990 to date the definition of new 
cases of TB in Canada has remained constant (i.e., “no documented evidence or history of 
previously active TB”) (Long et al., 1999). However, previously treated cases earlier referred to 
as relapse cases which included “documented evidence or history of previously active TB that 
became in-active” (Long et al., 1999) were changed to re-treatment cases from 2008 onwards 
(Menzies, 2014). Currently, re-treatment tuberculosis cases in Canada can be ascertained using 
either of the following criteria:  
A.  
(i) “documented evidence or adequate history of previously active tuberculosis that was 
declared cured or treatment completed by current standards, and  
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(ii) at least a 6-month interval since the last day of previous treatment and diagnosis of a 
subsequent episode of TB that meets the active TB case definition” (Menzies, 2014) OR  
B.  
(i) “documented evidence or adequate history of previously active TB that cannot be declared 
cured or treatment completed by current standards; and 
(ii) inactive disease for 6 months or longer after the last day of previous treatment;  
(iii) diagnosis of a subsequent episode of TB that meets the active TB case definition” (Menzies, 
2014). 
Additionally, TB cases may be defined based on diagnostic sites which are broadly categorized 
as respiratory or non-respiratory (Fisher, 2014). While respiratory TB comprises “pulmonary 
TB, plus TB of the pleura, the intrathoracic or mediastinal lymph nodes, nasopharynx, nose or 
sinuses”, non-respiratory rather refers to TB in all other body sites that are not within the 
purview of the disease sites of respiratory TB (Fisher, 2014). Cases included under both 
respiratory and non-respiratory may then be further subdivided; for example, respiratory TB in 
Canada is considered under the following subdivisions: primary, pulmonary and other 
respiratory (Public Health Agency of Canada, 2015) while non-respiratory includes miliary, lymph, 
central nervous system (CNS) and other sites (Fisher, 2014). 
2.4.2. TB case definition (s) in the United States 
 
The tuberculosis case definition in the United States has experienced substantial changes 
between 1953 and 1975 onwards. According to work published by Armstrong et al. (2014) the 
first TB case definition in 1953 encompasses individuals depicting either category A or B criteria:  
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A.   
 Cases with “bacteriological proof of TB or, in those without laboratory evidence, had other 
significant evidence of disease (e.g., characteristics chest radiograph or clinically active extra 
pulmonary TB)” (Armstrong and Miramontes, 2014) OR 
B. 
“Included previously unreported TB cases such as those with a history of active disease or 
previous treatment within the past 5 years” (Armstrong and Miramontes, 2014). 
However, “cases reported as (category B) one year were not precluded from being reported as 
(category A) cases in subsequent years” (Armstrong and Miramontes, 2014). This definition 
identified 84,304 per 100,000 TB cases in 1953 in the United States. Presently, the United 
States like Canada, confirms TB cases either through laboratory or clinical criteria (Armstrong 
and Miramontes, 2014). The detailed criteria for ascertaining TB cases in the United States are 
outlined in Table 2-3. 
Table 2-3: TB case definition in the United States 
 
Hierarchy Criteria Definition 
1. Laboratory confirmation-culture confirmed Isolation of M. tuberculous 
complex from a clinical specimen 
2. Laboratory confirmation-nucleic acid 
amplification test (NAAT) 
Demonstration of Tuberculous 
complex from a clinical specimen 
by NAAT  
3. Laboratory confirmation-positive smear for 
acid-fast bacilli (AFB) 
Demonstration of AFB in a clinical 
specimen when a culture has not 
been or cannot be obtained or is 
falsely negative or contaminated  
4.  Must meet all the following 
criteria 
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Clinical confirmation • Positive TB skin test result 
or positive interferon 
gamma release assay for M. 
tuberculosis 
• Other signs and symptoms 
compatible with TB (e.g., 
abnormal chest 
radiography, abnormal 
chest computerized 
topography scan, or other 
chest imaging study, or 
clinical evidence of current 
disease) 
• Treatment with two or 
more anti-TB drugs 
• A completed diagnostic 
evaluation 
5. Provider diagnosis The patient does not meet any of 
the above criteria but the provider 
believes the patient has a TB 
diagnosis 
 
Sources: Armstrong, L.R. and Miramontes, R (2014) & Reported TB in the US 2016 (CDC, 2017). 
 
2.4.3. Similarities and differences in surveillance case definition in Canada and the US over 
time 
 
From 1953-2015 national TB rates in Canada included new (“no documented evidence or 
adequate history of previously active TB”) (Public Health Agency of Canada, 2015) and previously 
reported cases (Gallant et al., 2014) whereas in the US from 1953-1974 (Armstrong and 
Miramontes, 2014) it included new active cases only and from 1975-2015 new and previously 
reported cases (Figure 2-1) (Armstrong and Miramontes, 2014). The case definition used in the 
US in 1953 was changed in 1975 onwards where “cases formerly classified as reactivation TB 
were included in morbidity data” (Armstrong and Miramontes, 2014). The 1975 increase in US 
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case rates (increased by 12.8%) resulted from the US change in surveillance case definition that 
now included previously reported cases (Armstrong and Miramontes, 2014; CDC, 2017).  
 
Figure 2-1: Case definition similarities and differences between Canada and US from 1953-2015 
 
Depending on which definition, whether clinical or bacteriological, is used, reported cases may 
vary. Insight into the impact of changes in case definition can be attained by considering the 
different criteria used to define TB surveillance cases.  
 
2.5. The impact of case definition change: a special case of tuberculosis   
 
Table 2-4 summarizes some scenarios that could have occurred concerning a number of cases 
reported in Canada if different case definitions were used. From 2010 to 2012 if TB cases in 
Canada were ascertained based on a case definition that utilizes only culture positive as 
diagnostic criteria, then at least 80% would have been confirmed as cases for treatment. On the 
other hand, the use of smear positivity as the only diagnostic criteria would have identified 35-
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40% as confirmed cases for treatment. Also, the use of smear positive, smear negative and 
culture positive as diagnostic criteria would have resulted in case ascertainment or 
confirmation of 71-76%. Comparing all three scenarios revealed that the number of cases 
reported might vary greatly depending on the case definition used. This comparison was based 
on only laboratory context. The identification of the majority of cases through the use of 
culture as a major diagnostic criteria was not surprising because compared to culture, smear 
microscopy has been found to have lower sensitivity (Ondimu et al., 2017) and specificity (Nour 
et al., 2011).  
Table 2-4: Case Definition Impact on Number of Cases Reported in Canada, 2010-2012 
 
 
 
 
 
 
 
 
Table 2-5 shows a comparison of TB cases based on four different case definitions. From 2007 
to 2016 in Saskatchewan, a case definition that captured all cases (new and previously reported 
cases) yielded a rate of 8.1 per 100,000 population compared to 7.4 per 100,000 population if 
only new cases were ascertained. While all cases assessed based on culture positivity resulted 
Year Total 
Casesa 
Culture Positiveb 
  N (%) 
Smear Positivec 
   N (%) 
Smear Positive, Culture 
Positive, and Smear 
Negative, Culture 
Positive N (%)** 
2010 
2011 
2012 
1587 
1618 
1685 
1268 (79.9) 
1334 (82.5) 
1367 (81.1) 
553 (34.9) 
643 (39.7) 
633 (37.6) 
1132 (71.3) 
1243 (76.8) 
1251 (74.2) 
a New and previously reported cases 
b c Cases which were laboratory-confirmed based on culture-positive or microscopy 
smear positive 
** Not including cases with unknown smear status.  
    Source: Tuberculosis in Canada 2012 (Public Health Agency of Canada, 2015)  
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in a rate of 6.1 per 100,000 population, those based on only smear positivity yielded a rate of 
3.0 per 100,000 population. 
 
Table 2-5: Number of Tuberculosis cases in Saskatchewan, 2007-2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: TB Prevention and Control Saskatchewan (TB Prev & Control, 2017).  
 
Similar to Canada, the case definition based on culture diagnostic criteria used in the US from 
2010 to 2012 identified more cases compared to the definition based on only smear microscopy 
(Table 2-6). Another difference was observed between laboratory confirmed cases and cases 
identified based on clinical criteria. From 2010-2012, a case definition based on laboratory 
Year All Casesa New Casesb All Culture Positive  
Casesc 
All Smeard 
2007 105 96 61 40 
2008 97 93 77 36 
2009 90 81 70 41 
2010 82 74 53 32 
2011 83 75 63 34 
2012 88 85 71 25 
2013 87 78 71 30 
2014 88 78 70 30 
2015 70 66 57 22 
2016 91 82 76 35 
Total 881 808 669 325 
Ave 88.1 80.8 66.9 32.5 
Ratee 8.1 7.4 6.1 3.0 
a New and previously reported cases 
b “No documented evidence or adequate history of previously active TB” (Public Health 
Agency of Canada, 2015)  
c d Cases which were laboratory-confirmed based on culture-positive or microscopy 
smear positive (Pai, 2014)  
e Rate per 100,000 population 
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criteria identified 76-78% whereas clinical case definition in the same time period was able to 
identify 16-17% of all cases. On the contrary, the clinical case definition identified more cases 
compared to 5-6% provider’s diagnosis (the patient does not meet any of the above criteria but 
the provider believes the patient has a TB diagnosis). The higher proportion of TB cases 
identified in both Canada and the US via the use of a culture positive case definition further 
suggests that cases of TB ascertained in most high-burden resource-limited countries which 
predominantly rely on smear microscopy may be underreported compared to those in well-
resourced settings (Parsons et al., 2011). 
Table 2-6: Case Definition Impact on Number of Cases Reported in the United States, 2010-2012 
 
 
 
 
 
 
 
 
The consequences associated with a case definition change or differences which include 
altering disease reporting, in addition to making the data incomparable overtime, have been 
observed and reported in other published studies (CDC, 1997; Goldstein et al., 2016; Peel Public 
Health, 2004). 
Year Total 
Cases 
Culture 
Positive 
  N (%) 
Smear 
Positive 
   N (%) 
Positive 
NAA 
N (%) 
Clinical Case 
Definition 
N (%) 
Provider 
Diagnosis 
N (%) 
2010 
2011 
2012 
11,157 
10,509 
9,940 
8,457 (76) 
8,087 (77) 
7,628 (77) 
69 (1) 
61 (1) 
38 (0) 
105 (1) 
121 (1) 
119 (1) 
1878 (17) 
1678 (16) 
1640 (16) 
648 (6) 
562 (5) 
515 (5) 
NAA-Nucleic Acid Amplification 
Source: Reported Tuberculosis in the United States, 2016 (CDC, 2017)35 
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2.6. The assessment of the impact of changes in case definition: a special case for 
tuberculosis 
 
Not only do case definition changes affect the number of cases reported but also often result in 
changes in the definition’s sensitivity and specificity (Teutsch et al., 2010). Ascertaining the 
performance of a diagnostic test depends on measures such as the sensitivity and specificity 
(Giesecke, 2017), which can be applied to case definitions as well. Depending on whether a 
surveillance or outbreak detection case definition was applied, the sensitivity and the specificity 
may vary (Stein et al. 2011). For instance, there is evidence that surveillance case definitions 
tend to have high sensitivity (Stein et al. 2011) whereas outbreak case definitions tend to be 
more specific especially in the later stage of an outbreak investigation when a stricter case 
definition is often applied (Stein et al. 2011). Differences between surveillance case definitions 
may also be observed by assessing sensitivity and specificity measures. While a larger 
proportion of true cases are identified using a more sensitive surveillance case definition 
(Giesecke, 2017), it is more likely to include a large number of cases not having the disease 
(false positives that arise because of the trade off with specificity) (Stein et al. 2011). 
In contrast, a more specific case definition captures individuals who truly have the disease 
under study but tend to miss some true cases (false negatives because of the trade-off with 
sensitivity) (Stein et al. 2011; Giesecke, 2017). For example, Kohl et al (2005) attributed partially 
the difference between West Nile cases reported in Colorado, Nebraska and Kansas to “higher 
specificity and lower sensitivity of the Kansas definition” (Kohl et al., 2005). Thus, a change in 
case definition to an expanded definition may lead to low specificity and high sensitivity 
whereas a change that leads to exclusivity in the definition may result in high specificity and low 
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sensitivity. The use of a strict case definition including situations where cases have been 
confirmed through clinical and laboratory means tends to “increase specificity and reduce 
misclassification of disease status” (Reingold, 1998). Since there is no clear cut decision as to 
how to apply the sensitivity and specificity to a case definition (Stein et al. 2011), balancing 
both on a case by case basis has been recommended (Teutsch et al., 2010). 
2.7. Methodologies for addressing the impacts of case definition change analytically 
 
Although there is the likelihood that misclassification might occur if studies span two time 
periods with different case definitions applied to a particular disease (Goldstein et al., 2016), an 
analysis focusing on or restricted to periods where the same case definition could be used. 
Analysis can then be accomplished with joinpoint/segmented regression to further break down 
this time span with similar case definitions. Alternatively, Bayesian approaches 
(Pourhoseingholi et al., 2012) could be used to adjust counts of disease cases for periods prior 
to the change in definition to periods after the definition change (e.g., TB counts from 1953-
1974 to the post 1974 counts). The latter approach was not considered for use in this thesis.   
Joinpoint also known as segmented regression (Kim et al., 2000) “describes changes in data 
trends by connecting several different line segments on a log scale” (Xie et al., 2014). This 
method provides the opportunity for statistical significant change-point in the trend to be 
identified (Kim et al., 2000). This approach may be inappropriate if only a limited number of 
data points are available. For instance, it is recommended that a minimum of seven data points 
should be available for a joinpoint regression to be considered (Kim et al., 2000).  
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Suppose , , … … … . . 	 , 	  are the observations for the response variable  (e.g. TB 
rate) and independent variable   (e.g. calendar year) where  = 1, 2, … … … . . ,  (Kim et al., 
2000). Then according to Kim et al. and Xie et al., the joinpoint regression model can be 
expressed as (Kim et al., 2000; Xie et al., 2014):  
Ey x⁄  = β + βx + αx − Ʈ … … … … + αƿx − Ʈƿ   Equation 2-1 
 
The regression coefficients are  ,  , !, … … … , !ƿ with the unknown break points 
represented by Ʈƿ′# and  − Ʈϒ =  − Ʈϒ for  − Ʈϒ > 0 and 0, otherwise. 
The response variable  or its transformed form can assume the following underlying 
distributions (Xie et al., 2014):  
y~Nµ*, σ, when y or its transformed values are homoscedastic.     
y~Nµ*, σ, when y or its transformed values are heteroscedastic. 
 
For this thesis, in order to fit a joinpoint to periods (1975-2015) where the same TB case 
definition were used in both countries, and the following steps were considered. The file 
containing the response variable (TB rates) and the independent variable (calendar year) was 
first uploaded in the joinpoint programming software (NIH, 2019A). This programming software 
was built by the National Institute of Health (NIH, 2019A) and has successfully been used to 
analyze 1971-2007 TB mortality trends in Spain (Llorca et al., 2012). 
In this software, there were several decisions to be considered in order to identify the best 
models and the optimal number of breakpoints. This included (a) the selection of equation 
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type: linear or non-linear; (b) selection of least square method: grid search method or Hudson’s 
method; (c) selection of maximum number of breakpoints; and (d) the method for selecting the 
optimal number of break points: permutation tests or Bayesian information criterion (BIC) 
(Jiang et al., 2010; NIH, 2018). Since normality assumption was not achievable using the raw TB 
rate data, the option of the log-linear approach was considered. While the log-linear approach 
enhances the data to achieve normality or at least be approximately normal, it also eases the 
interpretation of the trend (Kafle, 2014). Also, in terms of the least square approach, the grid 
search method was chosen over the Hudson’s method. The grid search method allows “finite 
number of discrete locations that are tested to find the best model fit” (NIH, 2018). 
Computational intensiveness has been identified as major difference observed between the 
two methods (Jiang et al., 2010). Jiang et al. found the Hudson’s method to be “10 times slower 
than the grid search method” (Jiang et al., 2010). The selection of the maximum number of 
breakpoints for the study data was guided by the recommended algorithmic default setting of 
the joinpoint program (NIH, 2019B). Thus, “the default value for the maximum number of 
joinpoint depends on the number of data points” (NIH, 2019B). From the grid search method, a 
maximum of nine break points can be considered (NIH, 2019B). Hence based on the 
recommended criteria and the allowable maximum number of breakpoints by the grid search 
method, a maximum number of 6 breakpoints were selected (NIH, 2019B). The optimal number 
of joinpoints was selected via the permutation tests which “ensure that the approximate 
probability of the overall Type I error is less than the specified significance level (e.g., default = 
0.05)” (NIH, 2018). The Bayesian information criterion has been found to be less parsimonious 
when compared to the permutation test (Jiang et al., 2010). The permutation test works by 
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testing the null hypothesis -: the number of breakpoints =Ʈ. against alternative hypothesis 
-/: the number of breakpoints = Ʈ/.  The algorithms start with  Ʈ. = 01 and Ʈ/ = 023 
where Ʈ/  deceases by 1 whenever the null hypothesis was accepted and Ʈ. increases by 1 
whenever the null hypothesis was rejected. The algorithm continues in the same manner until  
Ʈ. equals Ʈ/. This occurs when the final breakpoint is selected (NIH, 2018).   
 The slope estimates obtained from each model was used to compute the metric (annual 
percent change-APC) for the quantification of the change in the trend (Kim et al., 2017). For a 
break point with a slope  4, the APC can be calculated from the formula  
APC = 8expβ; − 1< ∗ 100  (Kim et al., 2017)                                         Equation 2-2 
To quantify the change in trend for the entire study period (e.g. 1975-2015), the average annual 
percent change was applied (Kim et al., 2017). This metric incorporates the trend transitions in 
it calculation (Clegg et al., 2009). 
2.8. The case definition: In Conclusion 
 
 Changes in case definitions, as evidence by exploring several diseases, highlights that for 
appropriate comparisons within and between populations, consistent ascertainment criteria of 
cases should be adopted or at minimum be openly reported. This confirms a statement by 
Luepker et al. (2003) that case definitions of diseases such as coronary heart disease (CHD) that 
are consistent and universal accepted allows for the “determination of rates and comparisons 
within and between populations” (Luepker et al., 2003). Detection of false negative cases, 
increases in reported cases of disease, underreporting of disease cases and reporting delays of 
cases of disease were the main consequences noted to arise from a case definition change. 
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Additionally, case definition change may also result in differences in sensitivity and specificity 
measures which may make data directly incomparable. 
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Chapter 2 provided an overview of the importance of assessing the case definition used for 
data collection before estimates from such data are compared. These are especially important 
when comparing the estimate of diseases between or within geographical regions. The 
investigation carried out in this chapter led to the important recognition of the differences in TB 
case definition used in the past between Canada and the United States. This information was 
essential especially to Chapter 3 of the thesis which sought to specifically embark on an in-
depth comparison of both past and present TB incidence in Canada and the United States. 
Furthermore, this chapter also provided options as to methods currently available in the 
literature which could be used to adjust or handle differences arising from revision/change in 
case definition in Chapter 3. The background information emerged from this chapter shed light 
on some difficulties that may arise from Canada-US TB rate comparison in Chapter 3 and 
possible methods to be applied to mitigate such difficulties. 
The Chapter 3 has been submitted for consideration for publication in the Canadian Journal of 
Public Health (Submission ID-CJPH-D-18-00285). In Chapter 2 and 3 I conducted literature 
review, cleaned the data, performed the statistical analysis, interpretation of results and wrote 
up the Chapters. 
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Chapter 3. Tuberculosis in Canada and the United States: A Review of Trends 
from 1953-2015 
 
3.1. INTRODUCTION 
 
Tuberculosis (TB) is a preventable and treatable disease (WHO 2018), that has not been 
eliminated in most parts of the world (Chiang et al. 2013) including Canada and the United 
States (Lönnroth et al. 2015). TB in North America date back to the 18th and 19th centuries 
(Grzybowski and Allen 1999; Grigg 1958), for which national incidence reporting in Canada and 
the United States only commenced in 1924 and 1953 respectively (Gallant et al. 2014; Woodruff 
et al. 2015). There are TB related similarities between these countries: high income (World 
Bank 2016), low TB incidence (Lönnroth et al. 2015),  similar surveillance programs (Mor et al. 
2008), isoniazid (INH) and rifampin (RMP) implemented for treatment at the same time 
(Menzies and Elwood 2014), treatment of Latent TB Infection (LTBI) implemented within a year 
(Mount and Ferebee 1961), and the majority of cases occurring in the Foreign-born (FB) 
population (Public Health Agency of Canada 2015; Centers for Disease Control and Prevention 
2017). There are some differences however: the United States in 1993 (Centers for Disease 
Control and Prevention 2017) was several years ahead of Canada in 1997 (Tuberculosis 
Prevention and Control Canada 2000) for first reporting TB with HIV/AIDS nationally, Canada 
ranks 6th and the United States 14th for highest proportion of Foreign-born population (OECD 
2018) and 18th and 29th for the highest net positive immigration respectively (Index Mundi 
2018). From 1953 to 1974 the United States surveillance case definition included only new 
cases compared to Canada with new and previously reported cases (Gallant et al. 2014; 
Armstrong and Miramontes 2014). In 1975, the United States changed its surveillance case 
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definition resulting in an increase in annual surveillance numbers (Armstrong and Miramontes 
2014). Considering this background, it was an unexpected observation over the last decade that 
TB rates in the United States declined more rapidly than in Canada (Public Health Agency of 
Canada 2015; Centers for Disease Control and Prevention 2017). 
Epidemiologically, time-trend analysis is a graphical procedure used to assess changes in 
disease patterns over time (Kim et al. 2000). Ely likened the analysis of trends which involve 
time as a major component to a screening tool needed to “decide whether a more intensive 
investigation into underlying causes is justified” (Ely et al. 1997). This highlights the need for 
exploring incidence trends as the first step in carrying out in-depth investigations of disease 
drivers to guide national and global goals in TB control. Explicit comparison of TB incidence 
rates over time between Canada and the United States has not been published. To better 
understand some of the differences we proposed to explore TB incidence rates in Canada and 
the United States over time and compare the national trends.  
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3.2. METHODS 
 
3.2.1 Incidence data 
 
This study used retrospective national annual TB incidence rate data from 1953-2015 retrieved 
from the Public Health Agency of Canada (PHAC) and the Centers for Disease Control (CDC), 
United States (Gallant et al. 2014; Centers for Disease Control and Prevention 2017; Gallant et 
al. 2017). Population data were obtained from Canada quinquennial and the United States 
decennial census data (Statistics Canada 2011; Grieco et al. 2012).  
The TB rate in Canada from 1953-2015 included new and previously reported cases. In the 
United States from 1953-1974 it included new active cases only and from 1975-2015 new and 
previously reported cases (Gallant et al. 2014; Armstrong and Miramontes 2014). Data on 
implementation of treatment drugs and treatment of LTBI, TB program funding cuts, case 
definition change, first reports of HIV, percent of HIV/TB co-infection, percent Foreign-born 
population and percent Indigenous population were obtained as listed in Table 3-1. Ethics 
approval was obtained from University of Saskatchewan ethics review board (U of S BIO#16-
329).  
  
 
6
0
 
Table 3-1: Sources of data list by reference number 
 
Metric Country Year & % Source 
Implementation date INH 
Implementation TLTBI 
Implementation date RMP 
TB program funding cuts 
Surveillance case definition 
change 
Canada and United States 
Canada and United States 
Canada and United States 
United States 
United States 
1952 
1961 
1968 
1970 
1975 
Menzies & Elwood (2014) 
Mount & Ferebee (1961) 
Menzies & Elwood (2014) 
United States Congress (1993) 
Armstrong et al. (2014) 
First national reported TB/HIV Canada 1997 Public Health Agency Canada (2000) 
United States 1993 Centers for Disease Control (2017) 
%foreign-born population  United States 2010 &12.9% Grieco et al. (2012) 
Canada 2011 &20.6% Statistics Canada (2011) 
%Indigenous (IND) population United States 2010 &1.7% Norris et al. (2012) 
Canada 2011 & 4.2% Statistics Canada (2011) 
% cases with HIV/TB co-infection United States 2012 & 7.2% Centers for Disease Control (2017) 
Canada 2012 & 8.0% Public Health Agency Canada (2015) 
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3.2.2. Data analysis 
 
A time-trend analysis comparing TB incidence rates between Canada and the United States 
from 1953-2015 was performed using Microsoft Excel 2016. The United States TB rate in 2010 
was directly standardized to the 2011 Canadian FB, IND and Non-Indigenous (NIND) population 
distribution. Thus, the crude United States FB, IND and NIND rate in 2010 was multiplied by the 
2011 standard Canadian proportion of FB, IND and NIND population to obtain the FB, IND, NIND 
adjusted rate. The TB rate share which is the proportion of the annual rate contributed by each 
country’s FB, IND and NIND was calculated by multiplying the crude FB, IND and NIND TB rate 
by the percent total population. In addition, joinpoint/segmented regression model was applied 
to identify points (years) with a statistically significant log-linear trend in TB case rates from 
1975-2015. This method is more robust than single summary trend statistics (Kim et al. 2000; 
Qiu et al. 2009). The Grid search method was used to test the locations for the best model (NIH, 
2018) and a maximum number of six joinpoints was used. Additionally, inferential permutation 
test was applied to select the appropriate optimal number of change points (NIH, 2018). The 
joinpoint method has been applied in several fields of research including TB and cancers (Kim et 
al. 2000; Baker et al. 2016). The annual percent change (APC) with 95% confidence intervals 
(CIs) were estimated from the models and p-values < 0.05 were considered a statistically 
significant joinpoint.  
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3.3. RESULTS 
 
3.3.1. Trend of Tuberculosis Incidence Rates from 1953-2015 
 
Fig 3-1 shows a comparison of TB incidence rates from 1953-2015. It shows that from 1953-
1974 rates in Canada were higher compared to the United States. From 1975-1985, rates were 
similar for both countries. From 1974 to 1975 the United States rate increased by 12.8% (case 
definition change), equalling the Canadian rate. During 1986-2000, rates in Canada continued 
to decline while an increase was observed in the United States. Between 2001 and 2004, rates 
were again similar. From 2004-2015 rates in Canada appeared to plateau whereas in the United 
States they decreased. Important events which were expected to influence rates are 
highlighted in Fig 3-1 and listed in Table 3-1. Fig 3-2, an expanded view of rates from 1997 to 
2015, showed that the Canadian rate declined throughout this period but at a significantly 
slower pace than the United States. 
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Figure 3-1: Tuberculosis incidence rates/100,000 in Canada and the United States from 1953-2015. Canada, solid black line; the 
United States interrupted black line 
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Figure 3-2: Tuberculosis incidence rate/100,000 in Canada and the United States from 1993-2015. The period of interest is 2004-
2015.  
Canada, solid black line; United, interrupted black line 
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3.3.2. Comparing Tuberculosis Incidence Rate 2010 and 2011 
 
Table 3-2 lists the population, percent total population and rate of TB by ethnicity for both 
countries. The total crude rate for Canada was 4.7 as compared to 3.6 for the United States. 
The Canadian rate share shows the Indigenous crude TB rate of 21.6 contributed 0.9% to the 
total annual rate; in the United States the crude rate was 2.9 and contributed 0.05% to the 
annual rate. Table 3-3 shows that the United States rate adjusted to the Canadian ethnic 
composition was 4.8 compared to the Canadian rate of 4.7. 
3.3.3. Joinpoint Trend in Tuberculosis Incidence Rate, 1975-2015 
 
The models of TB incidence rates were broken into six segments in the United States (1975, 
1985, 1992, 2000, 2007, 2011) and four segments in Canada (1987, 1993, 2003 and 2015), 
corresponding to where changes in the trend line occurred (Table 3-4). A decrease in APC was 
identified in all four segments in Canada whereas in the United States an increase of 1.9% was 
observed in 1985-1992. In Canada, the 1987-1993 segment decrease was not significant (APC=-
0.4%, CI -2.1 to 1.3); whereas, in the United States, for all six segments, the APCs were 
significant. The average APC in rate from 1975-2015 for Canada was significantly lower -2.9% 
compared to the United States -4.1%.
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Table 3-2: Population and TB rates by FB, IND and NIND Canada and the United States, 2010 & 2011 
 
Population  
Canada 2011 United States 2010 
Population Population 
% Total 
Rate 
Rate Share 
Population Population 
% Total 
Rate Rate 
 Share 
Foreign-born 6,775,800 20.2 16.3 3.3 39,900,000 12.9 17.1 2.2 
Canadian-born Indigenous 1,400,685 4.2 21.6 0.9 5,200,000 1.7 2.9 0.05 
Canadian born Non-
Indigenous 
25,200,203 75.6 0.7 0.5 263,600,000 85.4 1.6 1.4 
Total 33,476,688 100 4.7 4.7 308,700,000 100 3.6 3.6 
 
Table 3-3: Adjusted US TB rates using Canada percent population by FB, IND and NIND, 2010 & 2011 
 
Population  Canada % Population  Crude United States Rate  Adjusted United 
States Rate 
Foreign-born 20.2 17.1 3.5 
Canadian-born Indigenous 4.2 2.9 0.1 
Canadian born Non-Indigenous 75.6 1.6 1.2 
Total 100 3.6 4.8 
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Table 3-4: Annual percent change in TB case rates/100,000, Canada and US, 1975-2015 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: APC, Annual Percent Change; AAPC, Average Annual Percent Change; CI, confidence interval  
^ Significantly different from zero alpha=0.05 
 
 
United States Canada 
 
 
Segment 
Breakpoint Incidence Rate  
 
Segment 
Breakpoint Incidence Rate 
Lower        Upper 
end              end 
point           point 
APC 95% CI 
Lower         Upper 
Cl                    Cl 
Lower       Upper 
end            end 
point         point  
APC 95% CI 
Lower       Upper 
Cl                 Cl 
1 
2 
3 
4 
5 
6 
1975           1985 
1985           1992 
1992           2000 
2000           2007 
2007           2011 
2011           2015 
-5.1^ 
 1.9^ 
-7.1^ 
-3.7^ 
-6.9^ 
-3.5^ 
 -5.7             -4.6 
  0.7              3.3 
 -8.1             -6.2 
 -5.0             -2.5 
-10.3            -3.3 
 -5.8             -1.2 
1 
2 
3 
4 
1975          1987 
1987          1993 
1993          2003 
2003          2015 
-5.5^ 
-0.4 
-3.4^ 
-1.0^ 
-5.9             -5.0 
-2.1              1.3 
-4.1             -2.7 
-1.5             -0.6 
 
 
Full 
Range 
 
 
1975           2015 
AAP 
 
-4.1 
95% Cl 
 
-4.7                -3.6 
 
 
Full  
Range 
 
 
1975            2015 
AAPC 
 
-2.9 
95%Cl 
 
-3.2              -2.5 
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3.4. DISCUSSION 
 
This study is the first extended comparison of TB incidence rate trends between two North 
American low-incidence countries with similar national TB surveillance programs, Canada and 
the United States. Our prior expectations, possibly biased, were that rates and trends would be 
similar. The data showed that there were differences over six decades. The joinpoint intervals 
assigned by the regression model presented unequal intervals. All but the 1985-92 United 
States breakpoints showed a significant increase. All but the 1987-1993 Canada breakpoints 
showed a significant decline. These intervals quantified the line graph result. The United States 
average annual percent decline was significantly greater than the Canadian decline over the 41-
year interval, 4.1% compared to 2.9%. This compares to the United States designated 2015-20 
target of 53% (3 to 1.4/100,000) reduction over the 5 years or 10% per year and compares to 
the Canadian designated 1990-2015 target of 50% reduction (7.0 to 3.6/100,000) over 25 years 
or 2% per year (Public Health Agency of Canada 2014; Centers for Disease Control 2015). The 
Canadian and the United States targets compare to the WHO designated 2015-2025 target of 
50% reduction or 5% per year (WHO 2014).  
One of the advantages of using joinpoint was identifying intervals for which the change point 
was significant. It also quantified and compared the trends transitions for a more precise 
comparison, as well is more robust than single summary trend statistics (Qiu et al. 2009).  
The overall trend for the 63 year-interval (1953-2015) showed that the Canadian rates were 
higher between 1953 and 1974. Part of this difference, 10-15%, was due to Canada including 
new and previously reported cases compared to the United States reporting new cases only 
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(Gallant et al. 2014; Armstrong and Miramontes 2014). This was based on the US percent 
increase in 1975 due to previously reported cases. Further explanation is speculative since age, 
ethnicity, origin of birth, and gender were not available before 1970 (Personal communication 
Adam Langer CDC Feb 13, 2017 with permission). 
Rates were similar beginning in 1975 when the United States case definition changed and was 
similar to the Canadian definition. The United States rates rose in the mid-1980s coincident 
with a sizable proportion of cases resulting from HIV+/TB coinfection. The effect of TB program 
funding cuts beginning in 1970 also contributed (United States Congress 1993). Canadian rates 
declined more slowly during this interval probably related to HIV+/TB coinfection (Table 3-4) 
but with a lower proportion compared to the United States and less impact.  
The TB rate in the United States declined more rapidly thereafter such that by 2005 they were 
lower than the rate in Canada. This trend continued to the end of the observation period. Much 
of the difference related to the proportion of the FB population of 20.6% in Canada (2011 
census year) and 12.9% in the United States (2010 census year) (Statistics Canada 2011; Grieco 
et al. 2012). The majority of cases in both countries were FB, with comparable rates (Public 
Health Agency of Canada 2015; Centers for Disease Control and Prevention 2017). The United 
States rate when standardized to Canadian ethnic distribution was similar to the rate in Canada. 
A similar rate was the hypothesized outcome for two high-income low-incidence countries with 
similar surveillance programs. 
The proportion of FB population with the accompanying TB cases mostly explains the lower 
United States rate in the last decade since the difference in HIV+ TB cases narrowed. The rate 
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share confirmed that it was the major contributor to the total rate. Canada’s Indigenous rate 
was 38 times the Non-Indigenous Canadian born rate in 2010 but contributed only 19% to the 
annual rate (Public Health Agency of Canada 2015). The Non-Indigenous Canadian born 
contribution was 11% (Public Health Agency of Canada 2015).     
Different TB risk for different population groups is another possible cause of divergent trends in 
TB case rates between Canada and the United States. This and age-specific rates require more 
detailed investigations to quantify the effects of all the factors. 
Strengths and limitations 
The strength of the data was based on a six-decade interval of annual reports by Canada and 
the United States. From 1975 onward the case definition for both countries was the same. In a 
national context, Canada and the United States are comparable countries for high income and 
low TB incidence with similar epidemiological influences.  
Weaknesses of the data include the fact that Non-Indigenous Canadian and the United States 
born populations are not homogeneous. Canadian cases were not stratified beyond Non-
Indigenous Canadian-born as they were in the United States as Canada does not break down 
Non-Indigenous ethnicity in Canadian born cases. In the United States, the 2010 TB cases and 
incidence rates for Asian-American, African-American, and Hispanic-American were significant 
in proportion to total United States cases and rates. 
Divergent rates resulting from program performance could not be excluded. The comparison in 
this study was WHO surveillance reports by country. Comparison of program outcomes was 
beyond the scope of this study. Such a comparison would include percent of TB treatment 
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completion, the extent of drug resistance, and relapse, screening and uptake of treatment of 
LTBI. 
For comparative purposes the United States cases were standardized to Canadian ethnic 
categories in 2011. Since the proportions of ethnic categories change over time, the results of 
standardizing TB incidence rates would vary over time. 
3.5. CONCLUSIONS 
 
Canada and the United States TB incidence rates have been different for longer intervals over 
the last six decades than they have been the same. This was unexpected since both are low 
incidence and high-income countries, with identical TB surveillance programs. Surveillance case 
definition, TB program funding, HIV/TB co-infection, and TB in FB persons were the main 
contributors to the differences. Higher TB rates in the Canadian Indigenous population was a 
smaller contribution to the annual rate since the Indigenous proportion of the total population 
was small. From 2004-2015 the lower United States rates were mainly due to a larger 
proportion of FB persons in Canada. Incidence rates decreased in both countries from 1997 but 
significantly more rapidly in the United States.  Further exploration of contributing factors such 
as adjusting for age-specific rates and age composition in both populations is needed. 
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After accounting for case definition differences identified and also incorporating an adjustment 
method in Chapter 2 to Chapter 3, probable factors such as HIV/TB co-infection, ethnicity and 
shifts in demographic compositional factors (e.g., age) were identified as possibly responsible 
for incidence rate differences between the two countries. This background provided the basis 
for Chapter 4’s rationale to embark on an in-depth investigation into these factors. Following 
up Chapter 3 with Chapter 4 was vital to better elucidate rate differences especially in the last 
decade between the two countries. In Chapter 4 I conducted literature review, cleaned the 
data, performed the statistical analysis, interpretation of results and wrote up the Chapter. 
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Chapter 4. Comparing Tuberculosis in Canada and the United States: the impact 
of Foreign born and Indigenous populations and HIV/TB Co-infection 
 
4.1. INTRODUCTION 
 
Despite both Canada and the United States (US) having a well-resourced health care system 
(Martin et al., 2018; Ridic et al., 2012) coupled with huge financial commitments towards the 
reduction/elimination of TB (47,000 dollars in Canada and US$ 17, 000 to 482 000 per TB case 
respectively) (Menzies et al., 2008; Castro et al., 2016) as well similar TB surveillance programs 
(Mor et al., 2008), TB incidence rates are statistically significantly different between the two 
countries especially in the last decade (Essien et al., 2018). Among several other factors 
including age (Zhang et al., 2011) that may contribute to rate difference between these two 
populations, there is evidence that ethnicity and HIV strongly drive tuberculosis rates (Salinas et 
al., 2016; Houben et al., 2010).  
Between 2001 and 2011, Foreign-born (FB) and Indigenous (IND) populations in Canada have 
increased by 25.5% (Stat Can Ethnocultural Portrait, 2003; Stat Can Immigration and 
Ethnocultural Diversity, 2013) and 7.8% (Stat Can Aboriginal Peoples in Canada, 2003; Stat 
Canada, 2013); FB and IND increased by 28.5% (Malone et al., 2003; Grieco et al., 2012) and 
16% (Ogunwole, 2002; Norris et al., 2012) in the US between 2000 and 2010. These increases 
might have resulted in a shift in age and age-specific TB rate distribution in both countries. 
However, the extent to which the shift in age distribution might have affected the national TB 
rates has not yet been explored.  
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Furthermore, while both Canada (8.1%) and the US (8.0%) had almost the same proportions of 
reported HIV positivity among TB cases with known HIV status in 2010 (PHAC TB in Can 2012, 
2015; CDC, 2017), in 2012 the percent in HIV/TB was rather higher in Canada (8.0%) (PHAC TB in 
Can 2012) than in the US (7.2%) (CDC, 2017). Considering this background, an explicit 
comparison elucidating the contribution of FB, IND, and HIV/TB coinfection to differences in TB 
rates between the two countries is needed but yet lacking. 
As both migrant numbers (Stat Can Ethnocultural Portrait, 2003; Stat Can Immigration and 
Ethnocultural Diversity, 2013; Malone et al., 2003; Grieco et al., 2012) and IND population (Stat 
Can Aboriginal Peoples in Canada, 2003; Stat Canada, 2013; Ogunwole, 2002; Norris et al., 
2012) continued to increase in the two countries, coupled with challenges associated with HIV 
transmission rates (Hall et al., 2009). A better understanding of the pattern of influence of 
these factors would essentially help to inform tailored interventions (White et al., 2017; 
Unnikrishnan et al., 2015). Hence, we compared the rates of TB decline in FB and IND TB cases, 
and examined the impact of shifts in FB and IND population by age and age-specific rates, as 
well the influence of HIV/TB co-infection patterns over time between the two countries.         
4.2. METHODS 
 
4.2.1. Data 
 
Annual national retrospective Foreign-born age-stratified TB incidence case counts data in 
2001, 2006 and 2011 and Indigenous population in 2006 and 2011 were retrieved from Public 
Health Agency of Canada reports (Health Canada, 2003; PHAC TB in Can 2006, 2008; PHAC TB in 
Can 2012, 2015) and Centre of Disease Control (CDC) WONDER in the United States (CDC OTIS, 
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2018). In addition, population data were obtained from Canadian census (Stat Can 2001 Census 
of pop, 2001; Stat Can 2011, 2011; Stat Can 2006 Census of pop, 2006; Stat Can Aboriginal 
People in Can, 2006) and census data in the US (US Census Bureau, 2016; Pew Research Center, 
2014, US Census Bureau, 2017). Although Information on annual immigration numbers 
stratified by age distribution in Canada were available for four census years (2001, 2006, 2011 
and 2016) (Stat Can 2001 Census of pop, 2001; Stat Can 2011, 2011; Stat Can 2006 Census of 
pop, 2006; Stat Can 2016 Census of pop, 2016), Foreign-born TB incidence cases by age 
distribution were only available for three years (2001, 2006 and 2011). Despite the availability 
of immigration and age-stratified TB incidence case counts data in the United States from 1993-
2016 (CDC OTIS, 2018), all analyses were restricted to three years (2001, 2006 and 2011) due to 
data limitations in Canada.  
To better understand the trends, data on the percentage of cases with HIV+/TB co-infection 
were retrieved from annual TB reports in Canada (PHAC TB in Can 2008, 2015; Health Canada, 
2000; PHAC TB in Can 2008, 2012; PHAC TB in Can 2009, 2013) and in the US (CDC, 2017); as 
well, the list of WHO regions with Foreign-born TB that immigrate into both countries were 
identified (PHAC TB in Can 2012, 2015; CDC, 2012).  
4.2.2. Data Analysis 
 
The immigration numbers and TB incidence cases were retrieved for the age groups: less than 
15 years, 15-24 years, 25-44 years and 45-64 years and 65+ years, and the age-specific rates 
were estimated as cases of TB per 100,000 population. Using the 2011 immigration population 
as a standard population, Foreign-born TB incidence case counts in 2001, 2006 and 2011 were 
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directly standardized by multiplying the age-specific crude rate and age-specific distribution of 
the standard population to obtain the age-adjusted rates. The age-adjusted case rates obtained 
were further analyzed using a segmented regression model to assess years in which the TB 
incidence in the Foreign-born population significantly changed in the two countries. Segmented 
regression methods robustly subdivide models that are nonlinear in nature to linear with the 
aim of enhancing the efficiency of identifying change points (Kazemnejad et al., 2014). 
Inferential permutations tests were applied to detect and select the number of optimal change 
points (Kim et al., 2000) and the log-linear annual percent change and the associated 95% 
confidence intervals were estimated for each distinct segment. In a subsequent analysis, 
decomposition method/analyses were performed to assess to what extent the difference 
between Foreign-born crude TB incidence rates in Canada and US was attributable to changes 
in age group specific rate and age composition/structure. The decomposition approach 
explicitly described by Preston (Preston et al., 2001, p.28) was used and has successfully been 
used to compare California’s Foreign-born population TB rates in 2000 and 2010 (Oh, 2014). 
The decomposition of the differences in TB incidence rate in Canada from 2001 and 2006 was 
carried out by letting R2001 and R2006 represent the crude TB incident rates for the year 2001 and 
2006 immigrant populations in Canada and letting RZ2001 and RZ2006 represent the age group 
specific TB rate for 2001 and 2006 respectively. In addition, the age distributions of 2001 and 
2006 immigrant populations were represented as CZ2001 and Cz2006, where z denotes the age 
grouping of the population (under 15 years, 15-24 years, 25-44 years and 45-64 years and 65+ 
years). All the decomposition analyses were performed in Microsoft Excel 2016. 
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The contribution due to differences in age composition/structure was computed from the 
following equations:  
   Equation 4-1                                    
>?@, − ?@,A
@
 ∗ BC@, + C@,A2 D                                  
Likewise, the contribution due to differences in age specific TB rate was calculated from  
Equation 4-2  
>R*, − R*,A
*
∗ BC*, + C*,A2 D                                                   
The total contribution of both age composition/structure and age specific TB rate differences 
was computed using  
Equation 4-3 
>?@, − ?@,A
@
∗ BC@, + C@,A2 D    + >C@, − C@,A@
∗ B?@, + ?@,A2 D           
In order to obtain the proportion of differences that was attributable to age 
composition/structure and age-specific TB rate, formulas in (4.4) and (4.5) were used. 
Proportion of difference due to changes in age composition/structure was computed using 
Equation 4-4 
2
2 + F ∗ 100     GC          
2
? ∗ 100                                                    
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Proportion of difference due to changes in age specific TB rate was computed using 
Equation 4-5 
F
2 + F ∗ 100     GC          
F
? ∗ 100                                                    
All the remaining comparisons (2006-2011 and 2001-2011) including Indigenous population 
were performed in a similar manner for both countries.  
4.3. RESULTS 
 
4.3.1. Age-adjusted rates and segmented regression model 
 
Table 4-1 and Figure 4-1 summarize both the age-adjusted rates and a segmented regression 
model of Foreign-born TB incidence between Canada and the United States. In 2001, the age-
adjusted TB incidence rate observed in the United States immigrant population was higher 
(25.3 per 100,000 population) compared to that observed in Canada (19.9 per 100 000 
population). However, over a five-year period (2001-2006), the United States Foreign-born TB 
incidence rate experienced a more rapid decline of -3.7% compared to Canada which declined 
by -2.5%. From 2006-2011, Canada experienced a decline of -0.9% whereas US rates decreased 
by -3.6%. Overall, over the ten-year interval (2001-2011), the Foreign-born TB incidence rate in 
the United States declined more (AAPC=-3.7%; -4.1 to -3.2) compared to Canada (AAPC=-1.7; -
7.3 to 4.1). 
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Table 4-1: Foreign-born TB incidence rate comparison between Canada and the US 
 
 
 (^) – Significantly different from zero at alpha=0.05 
APC -Annual percentage change  
AAPC** - Average annual percentage change  
Cl – Confidence interval 
 
 
An examination of the pattern of migration based on WHO regions in both countries (Table 4-2) 
shows that besides controlling for age, region of birth of new migrants in part contributed to 
the differences in the TB rate decline between the two countries. Thus, while in Canada, the 
highest number of Foreign-born TB cases (40.6%) were reported in persons born in the Western 
Pacific, in the US, the highest was reported in persons born in the Americas (38.7%) with 
Mexico alone contributing 57.7% of the total Americas cases. 
 
Years 
                          Canada  
Foreign-born TB Incidence Rates 
                          United States 
Foreign-born TB Incidence Rates 
Age-
adjusted 
Rates per 
100,000 
population 
Unadjusted 
Rate per 
100,000 
population 
 APC 95% 
Cl 
Age-
adjusted 
Rates per 
100,000 
population 
Unadjusted 
Rate per 
100,000 
Population 
APC 95% 
Cl 
2001 
2006 
2011 
19.89 
17.53 
16.72 
18.8 
14.8 
13.5 
  25.27 
20.90 
17.39 
26.6 
21.9 
17.3 
  
Break 
points 
2001-
2006 
2006-
2011 
 
2001-
2011 
Segmented Regression Results 
   
-2.5% 
 
-0.9% 
 
AAPC* 
-1.7% 
 
 
 
 
 
-7.3 
to 
4.1 
   
-3.7% 
 
-3.6% 
 
AAPC* 
-3.7^% 
 
 
 
 
 
-4.1 
to -
3.2 
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Table 4-2: Proportion of Foreign-born TB by WHO region in Canada and the US, 2011 
 
 
** Out of 2483 cases in the Americas, 1432 cases were from individuals born in Mexico (57.7%). 
TB report in Canada and the United States, 2011 (PHAC TB in Can 2012, 2015; CDC, 2012). 
 
 
 
 
 
 
 
 
Canada United States 
WHO Regions N % Country N % 
Wester Pacific 444 40.6 Americas** 2483 
 
38.7 
Southeast Asia 273 24.9 Western Pacific 2048 31.9 
African  136 12.4 Southeast Asia 882 13.8 
European 108 9.9 African 500 7.8 
Americas 67 6.1 Eastern Mediterranean 280 4.4 
Eastern 
Mediterranean 
67 6.1 European 221 3.4 
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Figure 4-1: A plot comparing foreign born average annual percent change (AAPC), annual 
percent change (APC) and age-adjusted rate between Canada and the United States from 2001-
2011 
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Table 4-3 summarizes and compares the age-adjusted rates and annual percent change of TB 
incidence, specific to the Indigenous population, between Canada and the United States. In 
both 2006 and 2011, the age-adjusted TB incidence rates observed in Canada’s Indigenous 
population was higher compared to that observed in the United States. Results further revealed 
that from 2006-2011, the United States Indigenous population TB incidence rate declined more 
rapidly by -6.3% than in Canada which declined by -4.5%. 
Table 4-3: Indigenous Population TB incidence rate comparison between Canada and the US, 
2006-2011 
 
 
 
 
                 
 
 
 
 
 
 
 
 
 
 
*APC -Annual percentage change  
 
 Canada United States  
Years/Break 
Points 
 
Age-
adjusted 
Rates per 
100,000 
population 
Age-adjusted 
Rates per 
100,000 
population 
 
2006 
2011 
28.4 
22.5 
6.96 
5.03 
           Segmented Regression Results  
Break 
Points 
2006-2011 
APC* 
 
-4.5% 
APC* 
 
-6.3% 
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4.3.2. Tuberculosis in Canada and the United States: the impact of shifts in migrant’s 
population by age and age-specific rates from 2001-2006 
 
 The 1062 and 1042 cases of Foreign-born TB observed in Canada in 2001 and 2006 resulted in 
estimated crude incidence rates of 19.4 per 100,000 population and 16.8 per 100,000 
population respectively, which yielded a decrease of 2.6 per 100,000 population (Table 4-4). Of 
the absolute decrease in rate (2.6 per 100,000 population) observed in Canada between 2001 
and 2006, differences in the age group specific rate accounted for 101.1% of the decline and -
1.1% to compositional changes in age. Estimates higher than 100% mean if there were no 
compositional changes, there would have been a much higher decrease in TB incidence than 
what the study observed. In contrast, the negative estimate was an indication that 
compositional factors of age-specific TB rate were opposed by age group compositional factors. 
Although a similar pattern of contribution was observed in the United States for the same time 
interval, age composition/distribution increased Foreign-born TB rates more in the United 
States than in Canada. Thus, the 8033 and 7,844 cases of Foreign-born TB observed in the 
United States in 2001 and 2006 with estimated crude rates of 25.3 per 100,000 and 20.9 per 
100,000 respectively, resulted in an absolute decline of 4.4 per 100,000 population. The 
differences in age-group specific rate contributed 104.4% to the decline in the crude rate and -
4.4% to compositional changes in age from 2001-2006.  
The decomposition results from 2006-2011 revealed an absolute decrease of 0.5 per 100,000 
population and 3.5 per 100,000 population in Canada and the United States respectively (Table 
4-5). While both differences in age-group specific rate and changes in age 
composition/distribution contributed to the decline in Foreign-born TB incidence rate in the 
  
87 
 
 
two countries, the majority of the decline observed in Canada (80.1%) and the United States 
(66.7%) was attributed to differences in age-group specific rates. However, in comparing the 
contribution of changes in age composition/structure to the overall decline in rate between the 
two countries, the United States had a higher (33.3%) decline attributed to changes in age 
distribution/structure when compared to Canada (19.9%). 
As a whole, the pattern for a 10-year period (2001-2011) showed that the decline in Foreign- 
born TB incidence rate in Canada was largely due to changes/difference in age-group specific 
rate whereas in the United States, both changes in age composition/structure and age-group 
specific rate contributed more to the decline of Foreign-born TB rates (Table 4-6).  
4.3.3. Tuberculosis in Canada and the United States: the impact of shifts in Indigenous 
population by age and age-specific rates from 2006-2011 
 
The 320 and 303 cases of TB in Indigenous populations TB observed in Canada in 2006 and 2011 
resulted in estimated crude incidence rates of 27.3 per 100,000 population and 21.6 per 
100,000 population respectively, which equates a decrease of 5.7 per 100,000 population 
(Table 4-7). Of this absolute decrease in rate observed between 2006 and 2011, a difference in 
age- group specific rate accounted for 105.7% of the decline and -5.7% to compositional 
changes in age. The pattern of contribution observed in the United States was consistent with 
that observed in Canada. Thus, the decomposition results from 2006-2011 revealed an absolute 
decrease of 1.7 per 100,000 population in the United States. Of this, a difference in age-group 
specific rate contributed 104.3% to the decline in the crude rate and -4.3% to compositional 
changes in age. 
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4.3.4. Combined Percent of Contribution of Foreign Born and Indigenous Population Additive 
Components, 2006-2011 
 
The total sum of contributions of changes in age composition and age specific TB rate from 
2006 and 2011 FB and IND populations were used to estimate the additive components in Table 
4-8. Results of the decomposition analysis from 2006-2011 (Table 4-8) demonstrate that in the 
United States, 66% of the decline in the overall crude rate of TB was due to changes in Foreign-
born (age-specific TB rate distribution and age composition together) and 34% of the decline 
was attributable to changes in Indigenous populations (age-specific TB rate distribution and age 
distribution). In contrast, in Canada during the same interval, only 9.5% of the decline in the 
crude rate of TB was attributable to changes in Foreign-born (age-specific TB rate distribution 
and age distribution) whereas 90.5% of the decline was due to changes in Indigenous 
populations (age-specific TB rate distribution and age-distribution). 
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Table 4-4: Decomposition of an overall contribution of TB incidence rate in Foreign-born populations in Canada and the United 
States due to changes in age composition/structure and age group specific rate, 2001-2006                                     
    Canada                                   2001                                                     2006                         Contribution                                                                                                                 
                                                 
    United States                       2001                                                     2006                         Contribution                                                                                     
a-Estimated Foreign-born TB case rate per 100, 000 population              
b-Negative value/proportion indicates an increased in the contribution to TB rate     
c-Positive value/proportion indicates a decline to the contribution of TB rates 
d- Denominators for estimating rates were obtained from Statistics Canada        
f- Denominators for estimating rates were obtained from United States Census Bureau and American Community Survey 
   
 
 
 
 
 
 
 
    
Age/years Cases Population 
Estimated 
Ratea Cases Population 
Estimated 
Ratea Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
20 
115 
411 
221 
295 
316825 
470335 
1812050 
1820995 
1028280 
6.3 
24.5 
22.7 
12.1 
28.7 
23 
163 
377 
215 
264 
345705 
549255 
1975895 
2100805 
1215285 
6.7 
29.7 
19.1 
10.2 
21.7 
0.015 
-0.067 
0.276 
-0.059 
-0.194 
-0.022 
-0.455 
1.173 
0.640 
1.348 
Total 1062 5448485 19.4 1042 6186945 16.8                 b-0.029(-1.1%)                c2.684 (101.1%) 
   
 
 
 
 
 
 
 
    
Age/years Cases Population 
Estimatesf 
Ratea Cases Population 
Estimatesf 
Ratea Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
273 
1180 
3402 
1880 
1298 
2152000 
4506000 
14195000 
7701000 
3257000 
12.7 
26.2 
24.0 
24.4 
39.9 
203 
1107 
3266 
1968 
1300 
2151586 
4459490 
16374741 
10182185 
4301395 
9.4 
24.8 
19.9 
19.3 
30.2 
0.113 
0.577 
0.202 
-0.648 
-0.435 
0.206 
0.183 
1.811 
1.310 
1.053 
Total 8033 31811000 25.3 7844 37469397 20.9 b -0.191 (-4.4%)                    c 4.563(104.4%) 
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Table 4-5: Decomposition of an overall contribution of TB incidence rate in Foreign-born populations in Canada and the United 
States due to changes in age composition/structure and age group specific rate, 2006-2011 
     Canada                           2006                                                    2011                                                              Contribution     
                                     
  United States                2006                                                      2011                                                        Contribution 
 
a-Estimated Foreign-born TB case rate per 100, 000 population                  
b, c-Positive value/proportion indicates a decline to the contribution of TB rates 
d- Denominators for estimating rates were obtained from Statistics Canada        
f- Denominators for estimating rates were obtained from United States Census Bureau and American Community Survey 
   
 
 
 
 
 
 
 
    
Age/years Cases Population 
Estimated 
Ratea Cases Population 
Estimated 
Ratea Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
23 
163 
377 
215 
264 
345705 
549255 
1975895 
2100805 
1215285 
6.7 
29.7 
19.1 
10.2 
21.7 
21 
141 
418 
254 
271 
376915 
568215 
2103250 
2368000 
359385 
5.6 
24.8 
19.9 
10.7 
19.9 
0.002 
0.133 
0.174 
-0.103 
-0.087 
0.061 
0.422 
-0.003 
0.002 
-0.003 
Total 1042 6186945 16.8 1105 5775765 16.3            b 0.119 (19.9%)                   c0.479 (80.1%) 
   
 
 
 
 
 
 
 
    
Age/years Cases Population 
Estimatesf 
Ratea Cases Population 
Estimatesf 
Ratea Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
203 
1107 
3266 
1968 
1300 
2151586 
4459490 
16374741 
10182185 
4301395 
9.4 
24.8 
19.9 
19.3 
30.2 
122 
717 
2524 
1829 
1371 
1780881 
4211197 
16690753 
12492484 
2506259 
6.9 
17.0 
15.1 
14.6 
54.7 
0.083 
0.152 
-0.104 
-1.013 
2.049 
0.131 
0.900 
2.111 
1.418 
-2.221 
Total 7844 37469397 20.9 6563 37681574 17.4            b1.167 (33.3%)                   c 2.339 (66.7%) 
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Table 4-6: Decomposition of an overall contribution of TB incidence rate in Foreign-born populations in Canada and the United 
States due to changes in age composition/structure and age group specific rate, 2001-2011 
  Canada 2001 2011 Contribution 
                                                   
  United States                        2001                                                   2011                         Contribution                                                                                                                         
 
a-Estimated Foreign-born TB case rate per 100, 000 population                  
b, c-Positive value/proportion indicates a decline to the contribution of TB rates 
d- Denominators for estimating rates were obtained from Statistics Canada        
f- Denominators for estimating rates were obtained from United States Census Bureau and American Community Survey
Age/years Cases Population 
Estimated 
Ratea  Cases Population 
Estimated 
Ratea  Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
20 
115 
411 
221 
295 
316825 
470335 
1812050 
1820995 
1028280 
6.3 
24.5 
22.7 
12.1 
28.7 
21 
141 
418 
254 
271 
376915 
568215 
2103250 
2368000 
359385 
5.6 
24.8 
19.9 
10.7 
19.9 
0.015 
0.060 
0.472 
-0.173 
-0.289 
0.039 
-0.025 
0.900 
0.479 
1.713 
Total 1062 5448485 19.4 1105 5775765 16.3               b 0.085 (2.7%)                   c 3.106 (97.3%) 
Age/years Cases Population 
Estimatesf 
Ratea  Cases Population 
Estimatesf 
Ratea  Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
273 
1180 
3402 
1880 
1298 
2152000 
4506000 
14195000 
7701000 
3257000 
12.7 
26.2 
24.0 
24.4 
39.9 
122 
717 
2524 
1829 
1371 
1780881 
4211197 
16690753 
12492484 
2506259 
6.9 
17.0 
15.1 
14.6 
54.7 
0.199 
0.646 
0.064 
-1.744 
1.697 
0.333 
1.166 
3.956 
2.810 
-1.249 
Total 8033 31811000 25.3 6563 37681574 17.4               b 0.862 (10.9%)                c 7.016 (89.1%)     
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Table 4-7: Decomposition of an overall contribution of TB incidence rate in Indigenous populations in Canada and the United States 
due to changes in age composition/structure and age group specific rate, 2006-2011 
Canada 2006 2011 Contribution 
                                                   
  United States                        2006                                                   2011                         Contribution     
                                                                                                                                           
a-Estimated Indigenous TB case rate per 100, 000 population                  
b, c-Positive value/proportion indicates a decline to the contribution of TB rates 
d- Denominators for estimating rates were obtained from Statistics Canada        
f- Denominators for estimating rates were obtained from United States Census Bureau and American Community Survey 
   
 
 
 
 
 
 
 
    
Age/years Cases Population 
Estimated 
Ratea Cases Population 
Estimated 
Ratea Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
62 
71 
103 
57 
27 
348900 
212010 
331035 
224380 
56460 
17.8 
33.5 
31.1 
25.4 
47.8 
38 
59 
97 
82 
27 
392105 
254515 
367145 
304235 
82685 
9.7 
23.2 
26.4 
26.9 
32.7 
0.241 
                 -0.026 
0.579 
-0.677 
-0.438 
2.339 
1.867 
1.279 
-0.306 
0.809 
Total 320 1172785 27.3 303 1400685 21.6               b -0.321(-5.7%)                   c 5.988(105.7%) 
   
 
 
 
 
 
 
 
    
Age/years Cases Population 
Estimatesf 
Ratea Cases Population 
Estimatesf 
Ratea Age Composition       
Difference 
Specific Rate 
Difference 
Under 15  
15-24 
25-44 
45-64 
65+ 
9 
11 
54 
63 
28 
548994 
417483 
684393 
544997 
173564 
 
1.6 
2.6 
7.9 
11.6 
16.1 
12 
8 
26 
54 
32 
 
605084 
439927 
694446 
609383 
198166 
 
1.9 
1.8 
3.7 
8.8 
16.1 
-0.010 
0.008 
0.094 
                 -0.095 
-0.073 
-0.070 
0.139 
1.179 
0.634 
0.000 
 
Total 165 2369431 6.9 132 2547006 5.2               b-0.076(-4.3%)                c 1.882(104.3%)     
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Table 4-8: Combined Percent Contribution of Decline in TB Rates by Foreign-born and 
Indigenous Populations, 2006-2011 
 Contribution 
Population Canada   United States 
Foreign-born 
Indigenous  
Total 
0.598 (9.5%) 
5.6665 (90.5%) 
6.2645 (100%) 
3.506 (66%) 
1.805 (34%) 
5.311 (100%) 
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4.3.5. Trends in HIV/TB Coinfection from 1997-2012 
 
The numbers show that the highest percentage of cases with HIV+/TB coinfection recorded 
between 1997 and 2012 occurred in 1997 with 29% and 23% of cases reported in Canada and 
the US respectively (Figure 4-2). While the percentage of cases with HIV+/TB coinfection 
declined rapidly in Canada from 29% in 1997 to 11% in 1999, within the same time interval, 
cases with HIV+/TB coinfection in the US only declined by 3%.  
Unexpectedly, HIV+/TB coinfection cases in Canada sharply increased to 22% in 2002 after a 
rapid decline of 11% experienced in 1999. However, within the same time interval, the US 
continued to experience a steady downward trend in HIV+/TB coinfection case percent. In 
2004, the percentage of cases with HIV+/TB coinfection in Canada finally dropped to 11% and 
exhibited a continuously increasing and decreasing trend for the remaining eight years. In the 
US on the other hand, the percentage of cases with HIV+/TB coinfection have continuously 
declined since 2002. As a whole, over the fifteen years (1997-2012) investigated, descriptively 
there appear to be a more rapid decline in percentage of cases with HIV+/TB coinfection in the 
US than in Canada. However, a firm/explicit conclusion as to the extent to which HIV+/TB 
contributed to differences in rates between the two countries cannot be made by this thesis. 
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Figure 4-2: A plot of proportion of HIV+/TB co-Infection between Canada and US, 1997-2012 
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4.4. DISCUSSION 
 
The overall assessment of immigration patterns on TB incidence rates on both countries shows 
that over the ten (2001-2011) and five (2006-2011) years investigated, both Foreign-born and 
Indigenous TB incidence rates declined more rapidly in the US than in Canada with the major 
driver of the decline attributed to changes in Foreign-born and Indigenous population age- 
specific TB rates. As a whole, between 2006 and 2011, both changes in Foreign-born and 
Indigenous population contributed much to the decline in TB crude rates in the US whereas in 
Canada only changes in Indigenous population largely contributed to the decline in TB crude 
rates. In addition, over the same interval, the percentage of cases with HIV+/TB coinfection 
experienced an abrupt decline in the US compared Canada.  
The difference observed in Foreign-born TB rates between US and Canada may be due to the 
differing proportion in the number of Foreign-born individuals, especially those high incidence 
countries, who enter both countries (Saraiya & Binkin, 2000; Greenwood & Warriner, 2011). For 
instance, a study of fifty Metropolitan areas in the US found that a “10% increase in the number 
of high-incidence immigrants results in a 2.87% increase in TB among the Foreign-born 
population” (Greenwood & Warriner, 2011). In addition, as the Foreign-born population in the 
US increased from 601,708 in 1986 (Arnold, 1989) to 19.8 million in 1990 (Center for 
Immigration Studies, 1994), TB cases in Foreign-born individuals between 1986-1993 also 
increased from 21.6 percent (4925 cases) in 1986 to 29.6 percent (7346 cases) in 1993 
(McKenna et al., 1995). This has also been evident in Canada as an increase in the number of 
immigrants has shown a corresponding increase in the proportion of TB cases (Roth et al., 
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2012). For instance, while the migrant population in Canada increased by 2% between 1981-
1986, from 1986-1991 the population of Foreign-born only grew by 11% (Badets & Chui, 2004). 
This increase in Foreign-born populations probably led to an increase in the Foreign-born TB 
incidence during that period. Saraiya et al. found that between 1985-1995, Canada’s Foreign- 
born TB cases grew from 859 cases (40%) in 1985 to 1116 cases representing 58% in 1995 
(Saraiya & Binkin, 2000). 
The pattern of immigration is considered as another source of population change (Edmonston, 
2016). Gushulak et al. noted that traditional countries in Western and Central Europe 
predominantly known to supply immigrants to Canada and the US has changed since 1960 
(Gushulak & Macpherson, 2004). Reports show that countries supplying immigrants 
(Europe/Canada: 84%) (Radford & Budiman, 2018) that migrated most to the US in 1960 shifted 
from 1965-2015 to Latin America (51%) and Asia (25%) (Pew Research Center, 2015) whereas 
immigrants known to predominately migrate to Canada in the early years shifted to Asia 
(including the Middle East) (Stat Can 150 years of Immigration in Can, 2016). Data available in 
US from 2010-2014 shows that individuals born in Mexico accounted for the highest Foreign- 
born TB cases (CDC, 2015) whereas in Canada data from 1990-1998 and 2012-2014 revealed 
that immigrants from China, the Philippines and Vietnam recorded the highest Foreign-born TB 
cases (PHAC TB in Can 2012, Njoo & Long, 2000; PHAC TB in Can 2013, 2017; PHAC TB in Can 
2014, 2016). In comparing country of origin TB rates between Mexico and Asian countries 
including China, Philippines and Vietnam, Cash-Goldwasser et al. noted that TB rates in Mexico 
were lower than those observed in Asia, Africa and Eastern Europe (Brunette, 2018), suggesting 
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that the differences in Foreign-born TB rate between Canada and US reflect the differences in 
rates observed in the respective country of origin. 
Furthermore, differences in Foreign-born TB rate between the two countries could be in part 
attributed to a shift in immigrant population age structure and age-specific rate. The present 
time period (2001-2011) investigated in this study revealed that out of the absolute decrease in 
rate of 3.1 per 100, 000 population observed in Canada between 2001 and 2011, differences in 
age-specific rate accounted for 97.3% of the decline in Foreign-born TB rate and 2.7% 
attributed to changes in age structure. Conversely, in the same time period (2001-2011) 
investigated in the US, of the absolute decrease of 7.9 per 100,000 population observed, 
differences in age-specific rate accounted 89.1% of the decline in rate and 10.9% to changes in 
age composition. Despite the significant contribution of differences in age-specific rate to 
Foreign-born TB rates in both countries, changes in age structure contributed more to the 
decline in the US than in Canada. 
The present study suggests that changes in age-specific rates are a strong driver for rate 
difference between the two populations, which is consistent with a previously published study 
(Oh, 2014). Oh’s study on two Foreign-born populations in 2000 and 2010 in California found 
that differences in age-specific rate contributed 126.8% of the decline in the Foreign-born TB 
rate whereas age decomposition accounted for -26.8% (Oh, 2014). That study and other 
evidence from the literature support the concept that to achieve further declines in Foreign- 
born TB incidence, special attention should be given to age-specific TB interventions (Edelman 
et al., 2014).  
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Despite 16% growth in Indigenous populations observed in the US (Ogunwole, 2002; Norris et 
al., 2012) compared to 7.8% in Canada (Stat Can Aboriginal Peoples in Canada, 2003; Stat 
Canada, 2013), TB rates declined more rapidly in the US Indigenous population (-6.3%) 
compared to that in Canada (-4.5%). The difference observed in both could not be explained by 
changes in age composition and age-specific TB rates as both experienced a similar effect. The 
results found in this work for Indigenous populations in both countries is consistent with other 
published studies (Patel et al., 2017; Bloss et al., 2011). Between 2003 and 2008, the greatest 
decline of -27.4% was observed in Indigenous populations compared to other racial/ethnic 
groups in the US (Bloss et al., 2011). In contrast, between 2007 and 2008, the Indigenous 
population contributed to the slow decline in TB cases in the Canadian prairie provinces (Patel 
et al., 2017). 
As well, differing proportions of HIV/TB coinfection may have contributed to the differences in 
rates between the two countries. Although this thesis cannot make a firm/explicit conclusion as 
to the extent to which HIV+/TB contributed to differences in rates between the two countries 
due to data limitations (CDC, 2017; PHAC TB in Can 2008, 2012). The data on HIV/TB coinfection 
and national TB incidence rates from the US report (CDC, 2017) appear to show that since 2003 
the pattern of TB rate of decline in the US was consistent with the proportion of decline in 
HIV/TB coinfection. Whereas in Canada (Gallant et al., 2014), the pattern appears to show that 
the TB rate of decline was only consistent with the proportion of decline in HIV/TB coinfection 
between 2003 and 2008. This confirms the statement by Luetkemeyer that “the decline in HIV-
related TB in the United States and other industrialized countries has paralleled an overall 
decline in TB cases” (Luetkemeyer, 2013).  
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However, the divergence in the trend between TB rate and proportion of HIV/TB coinfection in 
Canada from 2009 onwards suggests that differences in rates between the two countries may 
not be solely dependent on HIV/TB coinfection but on multiple other factors as well. Thus, since 
the total number of TB and HIV co-epidemic cases in a setting highly depends on the extent of 
overlap existing between persons living with HIV and TB infected individuals (Raviglione et al., 
1996), and “narrow overlap between TB infected and HIV-infected population segments” exists 
in well-resourced settings/countries (Baussano et al., 2006), HIV infection has been found to 
predominantly offer a moderate contribution to the total TB cases in these settings (Baussano 
et al., 2006; Rose et al., 2002). For instance, Raviglione et al. noted that while rates of both HIV 
and TB infections are high among young adults in resourced limited countries, a corresponding 
elevated risk of TB and HIV co-epidemics occurs (Raviglione et al., 1996). However, in well-
resourced countries, the adults/elderly accounts for a large number of TB-infected cases, hence 
their risk of infection as it relates to HIV is lower (Raviglione et al., 1996). 
Strength and Limitation 
The present study used a decomposition method which robustly allowed for the difference in 
rates to be separated into two additive components (Preston et al., 2001; Oh, 2014). In 
addition, the direct standardization method used enabled the study to adjust for confounding 
by age on the rate difference. Despite the earlier highlighted strengths, the study also had some 
limitations. Thus, due to limited data available in Canada, with the exception of 2001, 2006 and 
2011, the present study could not compare Foreign-born and Indigenous TB rates in the two 
countries for other years. Also, a further challenge was encountered as the present study could 
not explicitly compare and elucidate the impact of HIV/TB coinfection on the national TB rate 
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due to data limitations in both countries. Despite several efforts put in place including national 
HIV/AIDS and TB surveillance systems to have  comprehensive national data on HIV/TB 
coinfection in Canada, underreporting still poses “serious limitations on the interpretation of 
HIV/TB coinfection in Canada”(Halverson et al., 2014) . Phypers noted that data “reported to 
the Canadian TB Reporting System (CTBRS) are inadequate to measure the HIV positivity among 
TB cases” (Phypers, 2007). Additionally, there is evidence that reporting of HIV status of 
individuals diagnosed with active TB in 2008 “varied across the provinces and territories ranging 
from 0% to 96%” (PHAC TB in Can 2008, 2012). Additionally, end users of US HIV/TB co-infection 
data have been encouraged to interpret their findings with caution as data on reported HIV/TB 
in the US national reports “are not representative of all TB patients with HIV infection” (CDC, 
2017). Also, data reporting differences hindered the present study from comparing the top 5 or 
10 countries of FB TB cases in Canada and the US. Thus, national TB reports in Canada captures 
FB TB cases only by STOP-TB partnership TB epidemiological regions which is similar to the 
WHO regions except for the division of Africa and Europe WHO regions into two separate 
groups (PHAC, 2015), whereas US reports capture both WHO regions and the top 30 countries 
(CDC, 2017). Hence the study comparison focused on only WHO regions. 
4.5. CONCLUSIONS 
 
As a whole, after adjusting for the effect of age, Foreign-born and Indigenous TB over the 
period investigated declined more in the US than in Canada. From this analysis, within Foreign-
born and Indigenous population, age is a strong driver for TB rates overall as evidenced by age-
specific rates differences. In addition, the pattern of decline of the proportion of cases with 
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HIV/TB co-infection in both countries corresponded to the pattern of decline in Foreign-born TB 
rate in the two countries. Ultimately, to achieve further declines in Foreign-born and 
Indigenous TB incidence which will consequently lead to a reduction in TB burden in both 
countries, special attention should be given to age-specific TB interventions.   
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The past and present assessment of TB incidence trends in both countries from Chapter 2 
through to Chapter 4, necessitated a follow up Chapter 5 to look ahead to the next nineteen 
years in terms of the TB rate in the two countries. This follow up chapter is to add to the 
Chapter 4 to project how further changes in the two populations especially due to immigration 
could impact TB rates in the two countries and whether meeting the WHO TB pre-elimination 
phase is possible. In Chapter 5 I conducted literature review, cleaned the data, performed the 
statistical analysis, interpretation of results and wrote up the Chapter. 
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Chapter 5. Forecast Analysis of Tuberculosis (TB) rates in Canada and the United 
States from 2017-2035 
 
5.1. INTRODUCTION 
 
Despite similar TB surveillance programs (Mor et al., 2008) in Canada and the US, TB rates over 
the past four decades have declined more rapidly in the US compared to Canada (Essien et al., 
2018). Although both countries have not achieved the proposed targets set for the reduction of 
TB incidence (Phypers et al., 2007; CDC, 1989), some progress has been made. In Canada, from 
2006-2015, a targeted TB rate of 3.6 cases per 100,000 population by 2015 was set (Phypers et 
al., 2007); however, the 2015 rate was 4.6 cases per 100, 000 population (Gallant et al., 2017). 
Likewise, in 1987, the US targeted a 38% reduction in TB rate from 9.3 per 100,000 in 1987 to 
3.5 per 100,000 in 2000 (CDC, 1989); however, the reported rate in 2000 was 5.8 per 100,000 
(CDC, 2017). Despite these unmet targets, WHO has proposed a pre-elimination target of < 1 TB 
case per 100,000 population in low-incidence countries, including Canada and the United 
States, by 2035 (WHO, 2014). However, no forecast analysis has been performed to monitor 
whether Canada and the United States will be able to achieve this WHO pre-elimination. 
The percent of Foreign-born, Indigenous and Non-Indigenous populations are changing in both 
countries (Norris et al., 2012; Grieco et al., 2012; Malone et al., 2003; Ogunwole, 2002; US 
Census, 2001; US Census, 2010; Stat Can, 2013; Stat Can, 2007; Stat Can, 2017) and the TB 
incidence, especially in Canada, continues to experience moderate yearly increase/decrease 
from 2006 to 2015 (Vachon et al., 2018; Public Health Agency of Canada, 2008) compared to a 
US decline of nearly 30.5% (CDC, 2017). Therefore, establishing accurate and useful prediction 
  
113 
 
 
models which take into account the complexities and the time lags with this disease could be 
helpful to best target prevention and management programs, as well monitor the set targets. 
This study aimed to forecast and then compare year-over-year TB rates between Canada and 
US from 2017-2035.  
5.2 METHODS 
 
5.2.1. Incidence data 
 
The national TB incidence rate data in Canada and the US for 1975 to 2016 were obtained from 
the Public Health Agency of Canada (PHAC) (Gallant et al., 2017; Vachon et al., 2018; Gallant et 
al., 2014) and the Centers of Disease Control (CDC) US reports (CDC, 2017). Additionally, all 
available data on the rates of TB for Foreign-born (FB), Indigenous (IND) and Non-Indigenous 
(NIND) persons (1993-2016) were also obtained for both countries (CDC, 2017; Public Health 
Agency of Canada, 2015; Public Health Agency of Canada, 2013; Public Health Agency of 
Canada, 2007). Both the TB rates in Canada and the US from 1975-2016 were estimated from 
new and previously reported cases (Gallant et al., 2017; Vachon et al., 2018; Gallant et al., 
2014; Armstrong & Miramontes, 2014) and expressed as a rate per 100,000 population. 
5.2.2. Modeling Approach 
 
An autoregressive integrated moving average (ARIMA) model (Newbold, 1983) was applied to 
forecast TB incidence rates in both Canada and the US from 2017-2035. ARIMA models are 
widely used (Wang et al., 2016) and have been reported to out-perform other statistical models 
for forecasting (Wang et al., 2018). The Box-Jenkins method (Oppenheim, 1978) was adopted to 
fit the ARIMA model for this study by following four steps which take into account the 
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stationarity of the data (mean, variance and covariance of the time series are constant over 
time) (Gupta & Udrea, 2013; Stadnytska, 2010), model selection, parameter estimation and 
model diagnostics (Jere & Moyo, 2016).  
In the first step for building the ARIMA model, a graph of the raw annual TB incidence rate was 
plotted against respective years to determine conditions that typically characterize non-
stationarity (time series do not have constant mean, variance and covariance) (Pfaff, 2008) 
including deterministic trends (i.e. increasing or decreasing trend) of the raw rate and whether 
the variation changes with the level of the time series (Xie et al., 2015). Once any of these were 
established, a log transformation (log 10) (Lütkepohl & Xu, 2012) and one stage differencing (d) 
were applied to stabilize the variance, detrend the data (Kugiumtzis & Tsimpiris, 2010) and 
create stationarity (Moosazadeh et al., 2014). Additionally, the Augmented Dickey-Fuller test 
for unit root (Stadnytska, 2010) was performed to inferentially evaluate the stationarity of the 
data. Thus, if the series had no unit root (alternative hypothesis) it was considered stationary; 
otherwise, it was considered non-stationary (Libanio, 2005). No unit roots “implies that the 
series has a finite variance which does not depend on time” (Libanio, 2005). To determine the 
possible lag values for autoregressive (p) and the moving average (q), the graphs of the 
autocorrelation function (ACF) and partial autocorrelation function (PACF) were depicted and 
examined for possible values of p and q. For model selection and estimation, several manually 
built models were considered based on several guess values of p and q. The model with the 
smallest Akaike’s Information Criterion (AIC) was selected as the best model for the study 
forecast. The goodness of the model fit was assessed through the residual correlation and the 
normality diagnostic plots. All analyses were performed in SAS 9.4. 
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To assess how the independent effect of changes in FB, FBP, IND and NIND TB may have on the 
national forecasted TB in both countries, a vector autoregression (VAR) model was applied 
(Zivot & Wang, 2006; Lütkepohl, 1999). The VAR model is described as a “natural extension of 
the univariate autoregressive model to dynamic multivariate time series” (Zivot & Wang, 2006). 
VAR models simply incorporate “each variable as a linear function of its own past values, the 
past values of all other variables being considered, and a serially uncorrelated error term” (Stock 
& Watson, 2001).  
The VAR model has been applied to several diseases including dengue hemorrhagic fever 
(Mahdiana et al., 2017) and pertussis (Zhang et al., 2016). Both estimated proportions of FB 
populations in both countries and national TB rates (NTBR), FBR, INDR and NIND TB rates from 
1993-2016 were used. The national TB rate was the response variable of interest in this thesis. 
Thus, to estimate and understand how FBR, INDR and NIND rates together project national TB 
rates from 2017 to 2035 in both countries. To begin the VAR process, the Johansen co-
integration test was applied to test for co-integration among all variables (NTBR, FB, IND and 
NIND TB rates) (Aljandali and Tatahi, 2018). Co-integration is defined as the “existence of a 
stationary linear combination of nonstationary time series” (Jones and Nesmith, 2007). Once its 
established that these variables were not co-integrated (Johansen test p>0.05), the unrestricted 
VAR model was used (Aljandali and Tatahi, 2018). Since stationarity is critical assumption to be 
met before the VAR model can proceed, the Augmented Dickey Fuller (ADF) test was applied to 
the first differenced log10 -transformed NTBR, FB, IND and NIND TB rates to test for stationarity 
(Aljandali and Tatahi, 2018). Once the stationarity is satisfied, the selection of the appropriate 
lag length for the model was carried out. For optimal lag length selection, the AIC criteria was 
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used where the lag length with the smallest AIC was considered optimal for used in the model 
(Liew, 2004). Once the optimal lag length is selected, the unrestricted VAR model was then 
fitted to the data. The Lagrange Multiplier (LM) test for residual autocorrelation (Bose et al., 
2017) and the Jarque-Bera test for normality were performed to assess the goodness of the 
VAR models (Caceres, 2006). A p-value greater than 0.05 for both tests was an indication that 
the models were good enough for the study forecast. Analysis on FB population proportions 
was carried out in a similar manner for both countries. 
 To further understand the extent to which different possible percent decrease or increase 
scenarios in FB, IND and NIND during the forecasted period might have on the overall TB rates, 
a “conditional forecast or scenario analysis” of the VAR was performed in Eviews software 
(Eviews, 2014). Eviews allows for scenario to be specified for VAR conditional forecast (Eviews, 
2014).  These scenarios were based on computed average annual percent change (AAPC) of 
actual TB rates from 2010-2016 in both countries (Table 5-1). The Joinpoint approach discussed 
in chapter 2, section 2.7 of the thesis was used to compute the AAPC. 
Table 5-1: Summary of proportions actual TB rate used for the “conditional forecast” 
 United States 
AAPC 2010-2016 
Canada 
AAPC 2010-2016 
FBR -4.0% -4.8% 
INDR -3.1% 3.0% 
NINDR -6.2% -3.0% 
 
The AAPC provides the opportunity for the “average annual percent changes over a period of 
multiple years” to be described by a single number (NIH, 2018). In addition, the Canadian 2011-
2016 FB population increase of 5% (Stat Can, 2016) was set as the highest percent change for all 
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FB population change scenarios. All VAR model results were depicted graphically for both 
countries. 
5.3. RESULTS  
 
Figure 5-1 depicts an initial plot of the raw TB incidence rates in Canada and in the US for the 
years 1975-2016. The overall plot showed a decreasing trend during the time period but with 
an increasing peak in the US between 1985 and 1992. The time plot also showed variation in 
the trends indicating lack of stationarity in the data. Stationarity was achieved through the 
application of log transformation, single difference for both the Canadian and the US data 
(Figure 5-2). Stationarity was supported by the Dickey Fuller unit root test which yielded p-
values of p<0.001 for Canada and p=0.037 for the US.  
 
Figure 5-1: Tuberculosis incidence rates/100,000 in Canada and the United States from 1975-
2016. Canada, solid black line; the United States interrupted black line 
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Figure 5-2: Difference of the log transformed data  
5.3.1. Autoregressive integrated moving average (ARIMA) model 
 
Although both plot showed no obvious trend, the first difference for Canada’s log rate showed 
more short term fluctuations compared to the US differenced log rates. To determine the best 
ARIMA model for the study forecast, a preliminary analysis of the stationary data was 
performed. The auto correlation (ACF) and partial auto correlation (PACF) plots produced by 
the initial analysis were examined for the appropriateness of potential models to be 
considered. From Figure 5-3 and 5-4, possible lag choices for both ACF and PACF including q=0, 
1 and 2 and p=0, 1, 2, and 3 were selected to fit several different ARIMA models.  
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Figure 5-3: Auto Correlation and Partial Auto Correlation plots for Canada 
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Figure 5-4: Auto Correlation and Partial Auto Correlation plots for United States 
 
Based on the smallest AIC’s, -134.0 and -164.7, the Autoregressive Integrated Moving Average 
ARIMA model of (3, 1, 0) for Canada where 3 is the order of the autoregressive part, 1 is the 
degree of first differencing and 0 is the order of the moving-average and ARIMA (1, 1, 0) for the 
US were selected as the best prediction model for the study forecast (Table 5-2). The white 
noise probability plots (Figures 5-5 and 5-6) show that the model residuals supported the white 
noise process. 
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Table 5-2: Model Selection and Parameter Estimate 
 
 Canada 
 
Models 
Coefficients SE SE AIC 
AR MA AR MA  
ARIMA (1, 1, 0) AR (1) -0.272  0.159  -133.1 
ARIMA (0,1, 1)  MA (1) 0.187  0.165 -132.2 
ARIMA (1, 1, 1) AR (1) -0.423 MA (1) -0.159 0.540 0.596 -131.3 
ARIMA (2, 1, 1) AR (1) -1.217 
AR (2) -0.271 
MA (1) -1.000 0.233 
0.164 
0.197 -131.1 
ARIMA (2, 1, 0) AR (1) -0.230 
AR (2) 0.135 
 0.169 
0.172 
 -131.8 
ARIMA (3, 1, 0) AR (1) -0.273 
AR (2) 0.225 
AR (3) 0.331 
 0.164 
0.172 
0.167 
 -134.0 
 United States 
ARIMA (1, 1, 0) AR (1) 0.578  0.131  -164.7 
ARIMA (0,1, 1)  MA (1) -0.433  0.145 -159.7 
ARIMA (1, 1, 1) AR (1) 0.564 MA (1) -0.021 0.236 0.286 -162.7 
ARIMA (2, 1, 1) AR (1) -0.032 
AR (2) 0.398 
MA (1) -0.575 1.341 
0.729 
1.389 -160.9 
ARIMA (2, 1, 0) AR (1) 0.588  0.163  -162.7 
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AR (2) -0.019 0.165 
ARIMA (3, 1, 0) AR (1) 0.586 
AR (2) 0.071 
AR (3) -0.160 
 0.163 
0.190 
0.166 
 -161.7 
 
SE-Standard Error 
 
In addition, the PACF plots (Figure 5-5 and 5-6) show that, with exception of lag 8 of the US 
plot, the remaining partial autocorrelation lie within the standard error bends. The histogram 
plots (Figures 5-7 and 5-8) also show that the distribution of the residuals is centered on zero 
with the bell shape clearly depicted; an indication of a normally distributed residual. The 
quantile-quantile (Q-Q) plot also shows that quite a number of points pass through the straight. 
This suggests that the theoretical quantiles are almost identical to the actual quantiles of the 
residuals. Hence, the normality assumption of the residuals was met (Figures 5-7 and 5-8). 
Therefore, the chosen models do not violate any of the model’s assumptions and were deemed 
good enough for the study forecast. 
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Figure 5-5: Plots of model residuals of annual TB rates recorded in Canada from 1975-2016 
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Figure 5-6: Plots of model residuals of annual TB rates recorded in the United States from 1975-
2016   
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Figure 5-7: Plots for normality test for model residuals for Canada TB model 
 
Figure 5-8: Plots for normality test for model residuals for the United State TB model 
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Table 5-3 summarizes the 2017 to 2035 forecast rate and 95% prediction intervals for TB 
incidence in Canada and the US. Based on predictions from our ARIMA models, the forecasted 
TB incidence rate for 2017 were approximately 4.6 and 2.8 per 100,000 population in Canada 
and the US respectively. These rates are expected to decline to approximately 2.2 and 1.3 per 
100,000 population by 2035.  
Table 5-3: ARIMA model forecasts for Canada and the United States, 2017-2035 
 
 Canada United States 
Year Point Forecast Lo 95 Hi 95 Point Forecast Lo 95 Hi 95 
2017 4.76 4.69 4.82 2.86 2.80 2.92 
2018 4.72 4.57 4.85 2.78 2.69 2.96 
2019 4.67 4.45 4.88 2.67 2.57 2.99 
2020 4.60 4.33 4.91 2.53 2.46 3.02 
2021 4.51 4.09 4.98 2.46 2.35 3.01 
2022 4.39 4.01 5.02 2.42 2.12 2.87 
2023 4.25 3.92 4.99 2.37 2.08 2.91 
2024 4.07 3.86 4.75 2.34 1.96 3.03 
2025 4.87 4.01 5.03 2.29 1.84 3.07 
2026 3.64 3.57 4.91 2.25 1.72 3.11 
2027 3.38 3.21 5.07 2.21 1.60 2.98 
2028 3.09 3.04 4.98 2.17 1.48 3.02 
2029 2.97 2.68 5.06 2.12 1.44 2.90 
2030 2.93 2.43 5.10 1.87 1.40 2.93 
2031 2.75 2.18 5.12 1.70 1.36 2.81 
2032 2.61 2.06 5.17 1.65 1.24 2.85 
2033 2.39 2.01 5.31 1.57 1.12 2.89 
2034 2.30 1.89 5.07 1.48 0.96 2.92 
2035 2.22 1.77 5.11 1.27 0.84 2.69 
 
Prediction interval is the interval in which the future TB rates are expected to lie 
Lo 95-lower limit of the 95% prediction interval 
Hi 95-Upper limit of the 95% prediction interval 
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5.4. Vector Autoregression (VAR) 
 
5.4.1 Results for changes in FB, IND and NIND TB rates 
 
No co-integration was found among FB, IND, NIND and NTBR (p=0.1654) in Canada. The 
Augmented Dickey-Fuller test revealed that the differenced log transformed TB rates of all 
three groups (FB: p=0.001; IND and NIND: p<0.001) in Canada met the stationarity assumption. 
Similarly, there was an absence of co-integration in the US variables (p=0.6774). The 
differenced log transformed United States FB, IND and NIND TB rates also passed the stability 
test with respective p-values of p=0.03, p=0.01 and p<0.001. The optimal lag length was found 
at lag 2 based on the smallest AIC values. 
Of the four-dimensional outcomes, the differenced log transformed national TB rate outcome 
for Canada conditional on the past realization values of NTBR, FBR, INDR and NINDR was found 
to be  
HFCIJKLM = 1.56 + 8.18 ∗ QFCLR − 0.06 ∗ HFCLR − 3.07 ∗ 1UCLR + 0.29 ∗
1UCLR − 1.11 ∗ QFCLR, + 0.65 ∗ HFCLR, − 3.99 ∗ 1UCLR, + 0.12 ∗ 1UCLR,.  
Equation 5-1 ………….(Model 1) 
Where t=time (in years), FBR= Foreign-born TB rate, INDR=Indigenous TB rate, NINDR = Non-
Indigenous TB rate, NTBRate=national TB rate and t-1, t-2 = represent the past 
values/observations. The LM test for the VAR model 1 revealed p-values of p=0.22 at lag 1 and 
p=0.24 at lag 2. Since the null hypothesis of the LM test which states that there is no serial 
correlation at lags agrees with the obtained p-values, the model’s assumption of no serial 
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correlation was met. The p-value of 0.85 obtained from the Jarque-Bera multivariate normality 
test also supported the assumption of normally distributed residuals. 
The forecast result from the VAR model (Figure 5-9) which accounted for FB, IND and NIND TB 
rates shows that the 2016 rate (4.8 per 100, 000 pop) in Canada was expected to decline to 
3.38 per 100,000 population by 2035. The “what if” analysis generated from the model 
revealed that a 4.8% decrease in FB rate each year from 2017 reduced the overall TB rate more 
in Canada when compared to the same percent decrease in IND rate. Similarly, a 3% increase in 
FB rate for each forecasted year increased the overall Canadian TB rate compared to same 
increase in IND TB rate (Figure 5-9). As a whole, the increase or decrease in FB rate contributes 
significantly to the overall decrease/increase in Canadian TB rate compared to the contribution 
of both IND and NIND rates (Figure 5-10).  
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Figure 5-9: Conditional forecast for possible future TB rates in Canada 
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Figure 5-10: Conditional forecast for possible future TB rates in Canada
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Of the four-dimensional outcomes, the differenced log transformed national TB rate outcome 
for US conditional on the past values of NTBR, FBR, INDR and NINDR was  
HFCIJKLM = −2.45 + 0.74 ∗ QFCLR + 0.95 ∗ HFCLR − 0.01 ∗ 1UCLR + 0.35 ∗
1UCLR + 0.22 ∗ QFCLR, − 0.10 ∗ HFCLR, + 0.14 ∗ 1UCLR, − 0.05 ∗ 1UCLR,.      
Equation 5-2     ……………… (Model 2)                                  
The model diagnostics based on the LM test showed that at both lag 1 and lag 2 with p-values 
p=0.61 and p=0.70 satisfied the no serial correlation assumption. Also the normality of residuals 
assumption was met as the Jarque-Bera revealed a p-value of 0.93.  
After accounting for FB, IND and NIND rates, the VAR model showed that by 2035 the US 
national rate was expected to decline to 1.31 per 100,000 population (Figure 5-11).  
The conditional forecast also revealed no difference between the baseline rate and the scenario 
where the forecasted FB rate was decreased by -3.1% and IND by -4.0%. In contrast, a 
difference concerning a decline in the overall TB rate in the US was observed between the 
baseline and the scenario where the forecasted FB rate was rather decreased by -4.0% and IND 
by -3.1%. Also, there was no differences in the overall rate in scenarios where either IND or 
NIND rates decrease by -4.0% and FB rate decrease by -3.1% (Figure 5-11). Figure 5-12 also 
revealed that wherever there was a higher percent decrease or increase in FB rate, a significant 
difference concerning a decrease or an increase in the overall TB rate was observed in the US. 
For instance, a decrease in FB rate by -6.2% each year starting 2017 decreased the overall TB 
rate in the United States compared to same decrease in NIND rate. As a whole, decreasing FB 
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rate by -6.2%, IND by -3.1% and NIND by -4.0% resulted in the lowest rate of 1.19 per 100,000 
population by 2035. 
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Figure 5-11: Conditional forecast for possible future TB rates in the United States 
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Figure 5-12: Conditional forecast for possible future TB rates in the United States
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5.4.2. Results for changes in FB population proportions 
 
In assessing the effect of changes in FB populations in both Canada and the US, the Johansen’s 
test found no co integration in the study variables (FBP, FBR, INDR and NINDR) with p=0.3928 
and 0.4476 respectively. The ADF test revealed that the differenced log transformed variables 
in Canada satisfied the stationarity assumption (FBP: p=0.0298; FBR: p=0.0087; NID and NIND: 
P<0.001). Of the five-dimensional outcomes, the differenced log transformed national TB rate 
outcome for Canada conditional on the past realization values of NTBR, FBP, FBR, INDR and 
NINDR was found to be 
HFCIJKM L = −0.029 − 0.052 ∗ QFXLR + 0.089 ∗ QFCLR + 0.093 ∗ HFCLR
− 0.042 ∗ 1ULR − 0.003 ∗ 1ULR + 0.069 ∗ QFXLR, − 0.191 ∗ QFCLR,
+ 0.042 ∗ HFCLR, + 0.048 ∗ 1ULR, + 1.320 ∗ 1UCLR, 
Equation 5-3 ……………(Model 3) 
Where FBP is the FB proportion in Canada. The assumption of no serial correlation was met as 
p-value for the LM test for VAR model at lag 1 was 0.28 and 0.35 at lag 2. In addition, the 
model’s residual was found to be normally distributed based on the Jarque-Bera test (p-value 
=0.95). The results from the unrestricted VAR plot shows that an increase in FB population by 
either 3% or 5% for each forecasted year increased the overall TB rate in Canada whereas a -3% 
decrease in FB population resulted in overall rate decreased (Figure 5-13).  
The US TB and FB population variables investigated showed no violation in the stationarity 
assumption as evidenced by the ADF test (PFB: p=0.0266; FBR: p=0.0113, INDR: p=0.0207 and 
NINDR: p=0.0229). Out of the five-dimensional outcomes, the differenced log transformed 
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national TB rate outcome for US conditional on the past realization values of NTBR, FBP, FBR, 
INDR and NINDR was 
HFCIJKM L = 0.176 − 10.943 ∗ QFXLR + 0.211 ∗ QFCLR + 0.541 ∗ HFCLR + 0.973
∗ 1ULR − 0.274 ∗ 1ULR + 10.867QFXLR, + 0.014 ∗ QFCLR, + 0.234
∗ HFCLR, − 0.010 ∗ 1ULR, + 0.256 ∗ 1UCLR, 
Equation 5-4 ………(Model 4) 
Both the LM test at lag 1 and lag 2 satisfied the no serial correlation with p=0.49 and 0.63. 
Additionally, the Jarque-Bera test (p-value =0.07) for the model residuals met the normality 
assumption. Scenario’s considered in Figure 5-14 showed that an increase or decrease in FB 
population in the US for each forecasted year resulted in an increase or decrease in overall US 
TB rate. Due to data limitations, impact of IND and NIND population changes were not 
considered in the analysis.    
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Figure 5-13: Conditional forecast of the Influence of changes of FB population in Canada 
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Figure 5-14: Conditional forecast of the Influence of changes of FB population in the United 
States 
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5.5. DISCUSSION 
 
Overall, the univariate forecasted TB rate using ARIMA models showed a gradually decreasing 
trend from 2017 to 2035, reaching a rate of 2.2 for Canada and 1.3 for the US by 2035. The 
current study found the attainment of the best prediction with ARIMA (3, 1, 0) for Canada and 
ARIMA (1, 1, 0) for the US. After accounting for FB, IND and NIND rates via the VAR model from 
1993-2016, the declining pattern of the forecasted rate from 2017 to 2035 in both countries 
remained unchanged. The narrow prediction interval observed in the ARIMA forecast in the 
present study also supported the prediction reliability of the models. From 2016 to 2035 the TB 
rate in Canada via the ARIMA model was predicted to be reduced by 54.1% whereas in the US 
rates were expected to be reduced by 56.2%. Although the WHO has projected a pre-
elimination (< 1 per 100,000 population) in low TB incidence countries by 2035 (WHO, 2014), 
our study predictions based on the two statistical approaches revealed that achievement of 
that set target might be difficult in both countries. The US forecast rates in 2035 were closer to 
the WHO set target compared to Canada. According to WHO, a decline of -17% and -16% in rate 
is required annually in Canada and the US to achieve the 2035 set target.  
The difference observed in the forecasted rates between the two countries could be largely 
attributed to FB in the US and FB and IND in Canada. All the scenarios considered in both 
countries revealed that the more the FB rate decreases or increases, the more the overall TB 
rate decreases or increases. A 3% increase in the Canadian FB rate each year from 2017 which 
would have resulted in a rate higher than the baseline rate was stabilized by a -4.8% decrease in 
IND rate for each forecasted year. This resulted in the stabilized rate being the same as the 
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baseline forecasted rate. A further -3% decrease in the Canadian NIND rate for each forecasted 
year did not change the rate stabilized by the -4.8% IND rate decrease. No significant difference 
was observed in the US overall rate in scenarios where either IND or NIND rate decreased by -
4% and FB by -3.1%. 
The declining trend of the forecasted TB rate in Canada is in line with a Canadian provincial 
forecast of TB incidence which projected a decline of 42% by 2030 (Klotz et al., 2013). A 
declining trend in TB incidence has also been forecast in New York in the US where a decline of 
2- 4.4% per year from 2015 to 2025 is projected (Fojo et al., 2017). Nationally, rates in the US 
have also been forecasted to decline from 2010 to 2020 with rates in US-born projected to 
decline by 47% and 6% among Foreign-born (Woodruff et al., 2013).  
The declining or increasing pattern of TB rate observed in both countries also reflect the 
pattern of population changes in the two countries. As FB populations increased in Canada and 
the US for each forecasted year, the overall TB rates in both countries also increased. Likewise, 
a decrease in the FB population also resulted in a decrease in overall TB rates in the two 
countries. Furthermore, in Canada FB TB cases increased by 3.1% from 2001-2011 (Public 
Health Agency of Canada, 2015; Health Canada, 2003). This in part could be due to a 5.9% 
increase in Canada’s net immigration during this same period (Edmonston, 2016). The effect of 
changes in population has also been observed in other low TB incidence countries (Hanway et 
al., 2016; Cain et al., 2007). Hanway et al. noted that for two European countries, Norway and 
Sweden, 0.54% and 0.37% increases in FB populations each year from 2000 to 2013 increased 
each country’s average annual TB notification rates by 3.85% and 2.64% respectively (Hanway 
et al., 2016).  
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Differences in rate as it relates to changes in population especially in FB populations in Canada 
and the US may be linked to immigration policies in the two countries (Borjas, 1993; Kaushal & 
Lu, 2015). After the major changes in immigration policies in 1962 and 1967 in Canada and 1965 
in the US (Boyd, 1976), the Canadian policy focus changed to target immigrants with 
“observable socioeconomic characteristics” where the US change focused on “applicant’s family 
ties with U.S. residents or citizens” (Borjas, 1993). Kaushal and Lu noted that as of 2006 “Canada 
surpassed the US in drawing highly-educated immigrants while continuing to attract fewer low-
educated immigrants” (Kaushal & Lu, 2015). This clearly shows that the immigration policies in 
both countries are different and have a differential impact on the pattern of immigrants and TB 
incidence in both countries. 
Although ARIMA models may have the limitation of being more effective for short-term 
forecasts (Levenbach, 2017, p.226), none of the model assumptions in the present study were 
violated. Moreover, the univariate ARIMA model showed consistent results as did the 
multivariate VAR model. In addition, the narrow prediction intervals supported the predicted 
reliability of rates in both countries. Several methods including dynamic models (Klotz et al., 
2013; Fojo et al., 2017), Bayesian approach (Fojo et al., 2017) and segmented linear regression 
models (Woodruff et al., 2013) have been carried out to forecast TB rates in both Canada and 
the US, all pointing to a decreasing trend in rates in the two countries. This clearly shows 
consistency in findings among the various methods used. As a limitation, the present study 
could not further assess the effect of seasonal variation on the predicted rates since national 
monthly/quarterly data were not available. Fares, after systematically reviewing published 
studies and synthesizing the evidence, found seasonality to be a probable factor that might 
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impact TB transmission dynamics (Fares, 2011). Due to data limitations, only data on ethnicity 
from 1993-2016 were considered for the VAR model. 
5.6. CONCLUSIONS  
    
Based on predictions from our ARIMA and VAR models for the two low TB incidence countries 
Canada and the US, the results show a decreasing trend in the total TB rate in both countries 
from 2017-2035. The prediction suggests that achieving the 2035 target set by the WHO could 
be a challenge for both countries. The “conditional forecast” analysis also revealed that to 
achieve further rapid declines in overall TB rates in both countries, more targeted interventions 
especially geared towards reduction of TB incidence in Foreign-born individuals are needed. 
Despite the study prediction only approximating actual rates, these findings can be utilized to 
further optimize current TB prevention and control programs. 
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Chapter 6. General Discussion and Conclusions 
 
This thesis primarily compared the TB incidence rate in Canada and the US by assessing where 
differences exist in the national TB incidence trend, sought possible explanations for differences 
in the trends and forecasted and compared TB incidence rates between the two countries. The 
investigation was carried out with four objectives in four manuscript-style chapters. A summary 
regarding the flow of the thesis, methodological considerations and insight into the impact of 
changes in population and immigration pattern, and differences in immigration policies and 
seasonality on TB are discussed in this chapter. 
6.1. The flow of the thesis 
 
Chapter 2 is an investigation into TB incidence in Canada by revealing some negative impacts 
that could be encountered if different case definitions were used for a particular disease (e.g., 
TB) that span two time periods. In addition, this chapter also provided insight into the use of 
joinpoint regression to analyze periods where the same TB case definition was used in both 
countries. Based on the evidence presented in Chapter 2, this necessitated a full-scale review 
into the national TB incidence trend from 1975-2015 in both countries, as presented in Chapter 
3. The time interval (1975-2015) was considered based on findings in Chapter 2 which shows 
that TB incidence data before and after 1975 in the United States were not comparable. Also 
through findings presented in Chapter 2, joinpoint regression was chosen for use in Chapter 3 
to analyze periods with comparable TB case definition. Chapter 4 which was born out of 
Chapter 3 carried out an in-depth investigation into probable factors identified in Chapter 3 as 
possibly responsible for TB incidence rate differences between the two countries. These factors 
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were HIV+/TB co-infection, ethnicity and demographic factors such as age. After assessing both 
past and present data on TB incidence trends in both countries, Chapter 5 was carried out to 
forecast and compare possible future TB incidence rates from 2017-2035 in both countries 
taking into account changes in the population structure over time.   
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Figure 6-1: Thesis flowchart 
        Thesis 
                                          Chapter 2 
• Impact on case definition change 
• US-prior 1975 and 1975 onwards TB incidence data not comparable 
• Possible methods to handle case definition change in trend analysis 
o Joinpoint Regression 
 
                                          Chapter 3 
• In-depth review of national TB trend from 1975-2015 
• Analytic technique based on Joinpoint Regression 
• Significant difference in trend between Canada and the US 
• Probable factors that might be responsible for the difference in the last 
decade 
o FB and IND population TB 
o HIV/TB 
o Demographic characteristics e.g., age 
                                          Chapter 4 
• In-depth investigation into FB and IND population TB, HIV/TB and Age in 
the last decade 
• Analytic techniques based on Decomposition Analysis and Direct 
Standardization  
• Differences in foreign born and Indigenous TB in both countries 
• Shift in age-specific rate was a strong driver of TB 
• Only proportion of cases with HIV+/TB were examined due to data 
limitation specifically relating to underreporting 
                                          Chapter 5 
• Forecast Analysis based on information on past and present TB incidence 
gathered in previous chapters 
• Analytic techniques based on ARIMA and VAR Models 
• “What if” analysis based on several scenarios on TB rate changes in 
subpopulations and percent change in population in general 
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6.2. CONCLUSIONS  
 
Changes in case definitions, as evidenced by exploring several diseases, highlights that for 
appropriate comparisons within and between populations, consistent ascertainment criteria of 
cases should be adopted or at minimum be openly reported. Also, change in a case definition 
may either result in exclusivity or expansion. The narrower the definition becomes, the higher 
the specificity and the lower the sensitivity; whereas, the broader the definition becomes, the 
higher the sensitivity and the lower the specificity. Detection of false negative cases, increases 
in reported cases of the disease, underreporting of disease cases and reporting delays of cases 
of the disease were other consequences noted to arise from a case definition change.  
Chapter 3 results show that Canada and the United States TB incidence rates have been 
different for longer intervals over the last six decades than they have been the same. Case 
definition change and HIV co-infection contributed to the 1980s US rate increase. TB rates 
decreased in both countries from 1997 but more rapidly in the US. Canada’s proportion of total 
population of Foreign-born and the Indigenous population was higher. Chapter 4 results also 
revealed that after adjusting for the effect of age, Foreign-born and Indigenous, TB over the 
period investigated declined more in the US than in Canada. From this analysis, within the 
Foreign-born and Indigenous populations, age is a strong driver for TB rates overall as 
evidenced by age-specific rate differences. In addition, the pattern of decline of the proportion 
of cases with HIV+/TB co-infection in both countries corresponded to the pattern of decline in 
Foreign-born TB rate in the two countries.  
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Finally, Chapter 5 results suggest a gradually decreasing trend in total TB rates in both countries 
from 2017-2035. The prediction suggests that achieving the 2035 TB reduction target set by the 
WHO could be a challenge for both countries. The “what if” analysis also revealed that to 
achieve a further rapid decline in overall TB rates in both countries, more targeted 
interventions especially geared towards reduction of TB incidence in Foreign-born populations 
are needed. 
6.3. METHODOLOGICAL CONSIDERATIONS 
 
6.3.1. Data availability, accessibility and reliability 
 
Data from national population census, national TB incidence and HIV+/TB percent were used 
for all analyses presented in the thesis. The national population census, national TB incidence 
and HIV+/TB data in Canada were obtained from Statistics Canada (Stat Can, 2001; Stat Can, 
2011; Stat Can, 2006; Stat Can, 2016) and Public Health Agency of Canada (Health Canada, 
2003; Public Health Agency of Canada, 2008; Public Health Agency of Canada, 2015; Health 
Canada, 2000; Public Health Agency of Canada, 2013). Similarly, the US national population 
census data were obtained from the Census Bureau (US Census Bureau, 2001; Pew Research 
Center, 2014; US Census Bureau, 2016; US Census Bureau, 2017), and national TB rate and 
HIV+/TB from the Centre for Disease Control (CDC, 2018; CDC, 2017). Due to data availability 
and accessibility constraints, analyses were mainly focused on data that spanned the following 
time intervals: national TB incidence rate 1953-2016 (CDC, 2017; Gallant et al. 2014); national 
population census 2001, 2006 and 2011 (Stat Can, 2001; Stat Can, 2011; US Census Bureau, 
2001; Pew Research Center, 2014; US Census Bureau, 2016; US Census Bureau, 2017; Stat Can, 
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2006) and HIV+/TB 1997-2012 (Public Health Agency of Canada, 2015; Health Canada, 2000; 
Public Health Agency of Canada, 2012; Public Health Agency of Canada, 2013). 
Additionally, differences in data reporting between the two countries (i.e. the top 5 or 10 
countries where TB cases originated from) constrained explicit comparisons. In the national TB 
reports in Canada, Foreign-born TB cases were grouped into STOP-TB partnership TB 
epidemiological region which is similar to the WHO regions, except for the division of Africa and 
Europe WHO regions into two separate groups, making a total of eight regions. The regions 
were: Established Market Economies (EME) and Central Europe (CEUR); Africa, high HIV 
prevalence (AFR-High); Africa, Low-HIV prevalence (AFR-Low); American Region-Latin American 
Countries (AMR); Eastern European Region (EUR); Eastern Mediterranean Region (EMR); South-
East Asian Region (SEAR); and Western Pacific Region (WPR) (Public Health Agency of Canada, 
2015). However, data on the top 5 or 10 FB TB countries in Canada were not available at the 
national level (Public Health Agency of Canada, 2015). The United States nationally reports both 
Foreign-born TB by WHO regions and by top 30 countries of birth (CDC, 2017). Hence all studies 
looking at immigration patterns in both countries were then constrained to WHO regions only.  
Other constraints encountered include different dates of the first national report on TB or 
HIV/TB cases and differences in reporting Foreign-born TB in both countries. For example, in 
Canada, the first national TB/HIV co-infected case was reported in 1997 (Health Canada, 2000); 
whereas in the US, the first case reported in 1993 (CDC, 2017). 
Despite data on HIV+/TB co-infection being available from 1997 to 2012 in both countries, due 
to underreporting-related issues across jurisdictions in both countries (CDC, 2017; Halverson et 
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al., 2014), a firm/explicit conclusion as to the extent to which HIV+/TB contributed to 
differences in rates between the two countries cannot be made. The Centre for Disease Control 
in their 2016 TB report in the US urges end users of HIV+/TB co-infection data to interpret their 
findings with cautions as data on reported HIV+/TB in the US national reports “are not 
representative of all TB patients with HIV infection” (CDC, 2017). 
6.3.2. Statistical methods for analysis 
 
Despite several advantages that might necessitate the use of ecologic or aggregate data, 
including “comparison of groups rather than individuals”, easy access to data at low cost and 
simplicity as it relates to analysis and presentation (Morgenstern, 1995), not much “attention 
was given to statistical methods or inference” (Morgenstern, 1995).  The reason for little 
attention being paid to statistical methodology advancement/development for ecologic studies 
could be due to the earlier soaring popularity of descriptive analyses (Morgenstern, 1995). 
Morgenstern noted that prior to the 1980s “ecologic studies were usually presented in the first 
part of epidemiology textbooks as simple descriptive analyses” (Morgenstern, 1995). However, 
after 1980, some techniques have emerged to advance the analytic approaches in an aggregate 
study (Morgenstern, 1995; Young, 2004).  
This thesis used five of the prominent analytic techniques in analyzing aggregated data. The 
methods used were direct standardization (Naing, 2000), joinpoint/segmented regression (Kim 
et al., 2000), decomposition analysis (Preston et al., 2001), autoregressive integrated moving 
average (ARIMA) model (Shumway and Stoffer, 2000) and vector auto regression (VAR) model 
(Zivot & Wang, 2006; Lütkepohl, 1999). These methods are not new to TB related research and 
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have gained some popularity in the field of TB as reported elsewhere (Oh, 2014; Moosazadeh et 
al., 2014; Baker et al., 2016; Gorbach, 2016). In order to ensure that none of the model specific 
(e.g., ARIMA) assumptions were violated, several tests were employed including the 
Augmented Dickey-Fuller test for unit root (Stadnytska, 2010), Lagrange Multiplier (LM) test for 
residual autocorrelation (Bose et al., 2017) and the Jarque-Bera test for normality (Caceres, 
2006).  
6.4. Factors investigated in the thesis: effect of changes in population and 
immigration pattern on TB incidence 
 
Changes in the population, such as demographic characteristics (e.g., age distribution), make 
increases or decreases in population size inevitable (UN, 2015). Not only do these changes 
impact the economic situation of a country (Thuku et al., 2013) but disease incidence including 
TB (CDC, 2013). For instance, when the Foreign-born populations in Norway and Sweden 
increased by 0.54% and 0.37% annually for a period of fourteen years (2000-2013), this resulted 
in an increase in average annual TB notification rates of 3.85% in Norway and 2.64% in Sweden 
(Hanway et al., 2016). Also, in 1993, the US age-specific TB rate among individuals in the age 
group 0-4 years was found to be 5.2 per 100,000 population whereas among the age group 15-
24 years was 5.0 per 100,000 population. However, for a period of eight years (1993-2000), the 
age-specific TB rate among persons aged 0-4 years declined to 2.8 per 100,000 population 
compared to 4.1 per 100, 000 population in individuals aged 15-24 years (CDC, 2017). This 
clearly depicts that as the US population increased by 9.2% from 1993 to 2000 (Byerly & 
Deardorff, 1995; US Census Bureau, 2002), a shift in the age-specific TB rate was observed 
(CDC, 2017). In addition, from 1993 to 2000, the population in the 0-4 year age group 
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decreased by 2.6% whereas persons aged 15-24 increased by 8.8% (Byerly & Deardorff, 1995; 
US Census Bureau, 2002). 
The pattern of immigration is considered as another source of population change (Edmonston, 
2016). These changes can have variable impact on the incidence of TB, especially due to 
immigrants from high TB incidence countries moving to low TB incidence countries (Lillebaek et 
al., 2002; Aldridge et al., 2016). In 2012, the percent of Foreign-born TB cases in Canada was 
65% (Public Health Agency of Canada, 2015). Out of this, 42% of the cases came from 
individuals who were born in the Philippines, China and Vietnam (Public Health Agency of 
Canada, 2015). In the same year in the US, the percent of Foreign-born TB cases was found to 
be 63% with individuals born in Mexico accounting for 20.9% of the cases and 25.1% from the 
Philippines, China and Vietnam (CDC, 2013). The source country TB rates for 2012 were 265 per 
100,000 population in the Philippines, 147 per 100, 000 population in Vietnam, 73 per 100, 000 
population in China (WHO, 2013) and 23 per 100, 000 population in Mexico (Delgado-Sanchez 
et al., 2015). This suggesting that differences, as it relates to TB incidence in both countries, 
could in part attributed to differences in source country TB incidence. 
6.5. Differences in immigration policies between Canada and the United States 
 
Prior to 1962 in Canada and 1965 in the United States immigration to both countries was based 
on a nationality quota system (Lo, 2011; Boyd, 1976). After the major changes in immigration 
policies in 1962 and 1967 in Canada and 1965 in the US (Boyd, 1976), the Canadian policy focus 
changed to target immigrants with “observable socioeconomic characteristics” where the US 
change focused on “applicant’s family ties with U.S. residents or citizens” (Borjas, 1993). 
   
161 
 
 
Kaushal and Lu noted that as at 2006 “Canada surpassed the US in drawing highly-educated 
immigrants while continuing to attract fewer low-educated immigrants” (Kaushal & Lu, 2015). 
This was further highlighted in a 2015 published report on Canada-US immigration policies 
comparisons (Canada Immigration, 2015; Orrenius & Zavodny, 2014). The report revealed that 
while more than 60% of newly admitted permanent residents in Canada came via an economic 
immigration program, in the US, new green card holders admitted via economic immigration 
categories accounted for only 16 percent (Canada Immigration, 2015; Orrenius & Zavodny, 
2014). This clearly shows that the immigration policies in both countries are different and have 
a differential impact on the pattern of immigrants and TB incidence in both countries. 
Moreover, as varying patterns of migration were attributed to different declining levels of TB 
rates in the majority of European countries (Gilbert et al., 2009), this could as well be linked to 
differences in country-specific immigration policies. 
 
6.6. Factors not investigated in the thesis: effect of seasonality on TB transmission 
 
Besides the facilitation of TB transmission by several factors including overcrowding (Kirenga et 
al., 2015) and HIV infection (Corbett et al., 2003), seasonality has also been suggested by most 
authors (Willis et al., 2012; Yang et al., 2016) as a probable factor that might have an impact on 
TB transmission dynamics and hence has to be considered in TB-related research (Wubuli et al., 
2017). However, according to Willis et al, the mechanism of the influence of seasonality on TB 
transmission remains unknown (Willis et al., 2012). In an attempt to explain this mechanism, 
Fares outlined some factors which are seasonally dependent and might play a role in the 
transmission of TB (Fares, 2011). These factors include “serum vitamin D level variability, indoor 
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activities and seasonal changes in immune function” (Fares, 2011). While some studies show 
that TB peaks in March and troughs in December (Bras et al., 2014; Yang et al., 2014), others 
showed that TB rather peaks between April-September and troughs between October-March 
(Douglas et al., 1996; Kelsey et al., 1999). Although evidence in published studies from different 
countries support the impact of seasonality on TB transmission (Bras, et al., 2014; Yang et al., 
2014; Douglas et al., 1996; Kelsey et al., 1999), the periods (months) as to when TB peaks or 
troughs is still not clear. Seasonality was not assessed in this study because national 
monthly/quarterly TB data were not available.                
Major Strengths and Limitations 
This thesis used varied and robust methods which allowed for the effect of potential 
confounding factors including age and ethnicity to be controlled and differences in rate to be 
separated into two additive components. Another strength was that a significant amount of the 
analytical work of this thesis was performed using data with long time lags which provided the 
opportunity for differences in TB incidence that existed in the past and present between the 
two countries to be explored. With regards to limitations, this thesis could not explicitly 
compare and elucidate the impact of HIV/TB co-infection on the national TB rate due to data 
limitation in both countries. Also, this thesis could not further assess the effect of seasonal 
variation on the predicted rates since national monthly/quarterly TB data were not available. 
Divergent rates resulting from program performance could not be excluded. The comparison in 
this thesis especially Chapter 3 was WHO surveillance reports by country. Comparison of 
program outcomes was beyond the scope of this thesis. Such a comparison would include 
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percent of TB treatment completion, the extent of drug resistance, relapse, screening and 
uptake of treatment of LTBI. 
6.7. Practical Significance 
 
The findings reported in this thesis have broadly deepened our understanding of the TB 
epidemiology in both Canada and the United States by shedding light upon some events in the 
past that affected TB incidence, factors that presently might be responsible for the differences 
in TB incidence and how shifts in population could impact the future incidence of TB in both 
countries. Secondly, findings in this thesis will be helpful to people managing tuberculosis 
interventions. Finally, this thesis has uncovered some challenges associated with the use of 
national HIV/TB co-infection data in both countries and encouraged all jurisdictional agencies in 
charge of HIV/TB to collect and report all HIV/TB-related data to national TB programs or public 
health agencies. 
6.8. Direction for future research 
 
This thesis has uncovered some gaps which would be essential to address in future research. 
This includes research involving comprehensive data on HIV/TB co-infection to elucidate the 
impact of HIV/TB co-infection on the national TB trend in both countries. As monthly or 
quarterly TB data becomes available at the national level, future research would be needed to 
investigate the effect of seasonal variation on TB incidence in both countries. 
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Appendix A. 1: Graphical Display of Research Rationale 
 
Annual TB rates between Canada and US 1984-2004 
 
 
   
 
 
 
 
 
 
 
 
 
Canada AAPC=-3.0^ 95%CI -3.8, -2.1 
US        AAPC=-3.2^ 95%CI -3.8, -2.5 
   
175 
 
 
Annual TB rates between Canada and US 2004-2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
Canada AAPC=-0.9^ 95%CI -1.3, -0.5 
US        AAPC=-4.6^ 95%CI -5.5, -3.7 
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Appendix A. 2: Graphical Representation of APC in TB Rate in Canada and the US 
from 1975-2015 
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Appendix A. 3: Graph Showing Joinpoint Models of TB Incidence Rate in Canada 
and the US from 1975-2015 
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